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A B S T R A C T
Background
Stroke is the third leading cause of disability worldwide. Physical activity is important for secondary stroke prevention and for promoting
functional recovery. However, people with stroke are more inactive than healthy age-matched controls. Therefore, interventions to
increase activity after stroke are vital to reduce stroke-related disability.
Objectives
To summarise the available evidence regarding the effectiveness of commercially available, wearable activity monitors and smartphone
applications for increasing physical activity levels in people with stroke.
Search methods
We searched theCochrane StrokeGroupTrials Register, CENTRAL,MEDLINE, Embase, CINAHL, SPORTDiscus, and the following
clinical trial registers:WHO International Clinical Trials Registry Platform,Clinical Trials, EUClinical Trial Register, ISRCTNRegistry,
Australian and New Zealand Clinical Trial Registry, and Stroke Trials Registry to 3 March 2018. We also searched reference lists, Web
of Science forward tracking, and Google Scholar, and contacted trial authors to obtain further data if required. We did not restrict the
search on language or publication status.
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Selection criteria
We included all randomised controlled trials (RCTs) and randomised cross-over trials that included use of activity monitors versus
no intervention, another type of intervention, or other activity monitor. Participants were aged 18 years or older with a diagnosis
of stroke, in hospital or living in the community. Primary outcome measures were steps per day and time in moderate-to-vigorous
intensity activity. Secondary outcomes were sedentary time, time spent in light intensity physical activity, walking duration, fatigue,
mood, quality of life, community participation and adverse events. We excluded upper limb monitors that only measured upper limb
activity.
Data collection and analysis
We followed standard Cochrane methodology to analyse and interpret the data. At least two authors independently screened titles and
abstracts for inclusion. We resolved disagreements by consulting a third review author. We extracted the following data from included
studies into a standardised template: type of study, participant population, study setting, intervention and co-interventions, time-
frame, and outcomes. We graded levels of bias as high, low, or unclear, and assessed the quality of evidence for each outcome using the
GRADE approach.
Main results
We retrieved 28,098 references, from which we identified 29 potential articles. Four RCTs (in 11 reports) met the inclusion criteria.The
sample sizes ranged from 27 to 135 (total 245 participants). Time poststroke varied from less than one week (n = 1), to one to three
months (n = 2), or a median of 51 months (n = 1). Stroke severity ranged from a median of one to six on the National Institutes of
Health Stroke Scale (NIHSS). Three studies were conducted in inpatient rehabilitation, and one was in a university laboratory. All
studies compared use of activity monitor plus another intervention (e.g. a walking retraining programme or an inpatient rehabilitation
programme) versus the other intervention alone. Three studies reported on the primary outcome of daily step counts.
There was no clear effect for the use of activity monitors in conjunction with other interventions on step count in a community setting
(mean difference (MD) -1930 steps, 95% confidence interval (CI) -4410 to 550; 1 RCT, 27 participants; very low-quality evidence),
or in an inpatient rehabilitation setting (MD 1400 steps, 95% CI -40 to 2840; 2 RCTs, 83 participants; very low-quality evidence).
No studies reported the primary outcome moderate-to-vigorous physical activity, but one did report time spent in moderate and
vigorous intensity activity separately: this study reported that an activity monitor in addition to usual inpatient rehabilitation increased
the time spent on moderate intensity physical activity by 4.4 minutes per day (95% CI 0.28 to 8.52; 1 RCT, 48 participants; low-
quality evidence) compared with usual rehabilitation alone, but there was no clear effect for the use of an activity monitor plus usual
rehabilitation for increasing time spent in vigorous intensity physical activity compared to usual rehabilitation (MD 2.6 minutes per
day, 95% CI -0.8 to 6; 1 RCT, 48 participants; low-quality evidence). The overall risk of bias was low, apart from high-risk for blinding
of participants and study personnel. None of the included studies reported any information relating to adverse effects.
Authors’ conclusions
Only four small RCTs with 274 participants (three in inpatient rehabilitation and one in the community) have examined the efficacy
of activity monitors for increasing physical activity after stroke. Although these studies showed activity monitors could be incorporated
into practice, there is currently not enough evidence to support the use of activity monitors to increase physical activity after stroke.
P L A I N L A N G U A G E S U M M A R Y
Do activity monitors help adults with stroke become more physically active?
Review question
We reviewed the available evidence regarding the effectiveness of commercially available, wearable devices (for example pedometers,
Fitbit, and Garmin watches) and smartphone applications (for example Runkeeper, Fitbit application) for increasing physical activity
levels for people with stroke.
Background
Promoting physical activity is an important health intervention for people with stroke. The association between health and physical
activity is well known. People with stroke face additional challenges to engage in sufficient physical activity for health benefits, and are
often very inactive. Increasing physical activity levels in stroke survivors in both hospital and community settings is important.
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Providing feedback to stroke survivors about their physical activity levels is one strategy that could change their behaviour and increase
physical activity levels. Wearable devices that count steps or measure activity, or smartphone applications that provide feedback about
physical activity could be useful. Understanding how effective such devices are to increase physical activity has the potential to benefit
all people after stroke.
Study characteristics
We included four trials in this review, comprising 245 participants, ranging in age from 22 to 92 years. Three trials measured physical
activity outcomes after the treatment period. Trials were conducted in hospital and community settings. All participants were able
to communicate and provide informed consent, and all were able to walk at least five steps without supervision or assistance. The
experimental groups in the trials received feedback at least daily on the number of steps taken.
Search date
We searched for studies up to 3 March 2018.
Key results
We found that the use of wearable activity monitors to provide feedback on physical activity did not increase physical activity levels in
people with stroke. No conclusions could be drawn regarding the influence of stroke severity, walking ability, stroke survivor age, or
time poststroke on the outcomes. The four included studies were conducted in different settings, and used different outcome measures,
which limited the ability to combine data. No study reported whether the use of physical activity monitors was harmful. More research
is needed to determine if they are effective.
Quality of the evidence
Using the GRADE approach, the quality of the evidence was low to very low, due to the small number of studies, small sample sizes,
and because no study was able to blind the participants or the therapists delivering the intervention (they were aware that a device was
being used and aware of the feedback that was being provided by the device).
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Activity monitor plus other intervention compared to other intervention alone for increasing physical activity in adult community dwelling stroke survivors
Patient or population: increasing physical act ivity in adult community dwelling stroke survivors
Setting: community
Intervention: act ivity monitor plus other intervent ion
Comparison: other intervent ion
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with other inter-
vention
Risk with activity moni-
tor plus other interven-
tion
Number of steps per
day (x 1000) at end
of intervent ion (> 6
months post-stroke)
The mean number of
steps per day (x 1000)
at end of intervent ion (>
6 months post-stroke)
was 7.09 Steps (x 1000)
MD 1.93 Steps (x 1000)
lower
(4.41 lower to 0.55
higher)
- 27
(1 RCT)
⊕©©©
Very low 123
Based on a single small
study in which part ic-
ipants and personnel
were not blinded
Time spent in MVPA
(minutes) at the end
of the intervent ion (>
6 months post-stroke) -
not reported
- - - - -
Sedentary t ime (min-
utes) at the end of
the intervent ion (> 6
months post-stroke) -
not reported
- - - - -
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Time spent in light in-
tensity act ivity (m in-
utes) at the end of
the intervent ion (> 6
months post-stroke) -
not reported
- - - - -
Total t ime walking
(minutes) at end of in-
tervent ion (> 6 months
post-stroke)
The mean total t ime
walking (minutes) at
end of intervent ion (>
6 months post-stroke)
was 141 minutes per
day
MD 39 minutes per day
lower
(83.9 lower to 5.9
higher)
- 27
(1 RCT)
⊕©©©
Very low 123
Based on a single small
study in which part ic-
ipants and personnel
were not blinded
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High certainty: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Risk of bias: part icipants and personnel were not blinded
2 Risk of bias: it was unclear if the sequence was generated randomly and if allocat ion was concealed
3 Imprecision: the study included a small sample and conf idence intervals were wide
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B A C K G R O U N D
Description of the condition
Between 1990 and 2010, the absolute numbers of people living
with stroke increased by 84% worldwide, with stroke now the
third leading cause of disability globally (Feigin 2014). As such,
the disease burden of stroke is substantial. It has been estimated
that 91% of the burden of stroke is attributable to modifiable
risk factors, such as smoking, poor diet, and low levels of physical
activity (Feigin 2016). A low level of physical activity (less than
four hours per week of activity of at least moderate intensity) is
the second highest population-attributable risk factor for stroke,
second only to hypertension (O’Donnell 2016). The promotion
of physical activity, which has been defined as body movement
produced by skeletal muscles resulting in energy expenditure, is
therefore, an important health intervention for people with stroke
(Caspersen 1985).
The association between health and physical activity is well estab-
lished. Prolonged, unbroken bouts of sitting is a distinct health
risk, independent of time engaged in regular exercise (Healy 2008).
There is evidence from cross-sectional and longitudinal studies
that high sitting time and low levels of physical activity contribute
to poor glycaemic control (Owen 2010). Three systematic reviews
and meta-analyses of observational studies have confirmed that af-
ter adjusting for other demographic and behavioural risk factors,
physical activity is inversely associated with all-cause mortality in
men and women (Nocon 2008; Löllgen 2009; Woodcock 2011).
Yet despite this knowledge, populations worldwide are becoming
more sedentary, and physical inactivity has been labelled a global
pandemic (Kohl 2012).
Directly after a stroke, people should be admitted to hospital for
co-ordinated care, and commencement of rehabilitation (SUTC
2013). Early rehabilitation after stroke is frequently focused on the
recovery of physical independence, particularly walking (Pollock
2014). Recovery after stroke is enhanced by active practice of spe-
cific tasks, and greater improvements are seen when people with
stroke spend more time in active practice (Veerbeek 2014). Yet
findings from research conducted around the world indicate that
people in the first few weeks and months after stroke are phys-
ically inactive in hospital settings, with around 80% of the day
spent inactive (sitting or lying; West 2012). These high levels of
inactivity are concerning, because recovering the ability to walk
independently is an important goal of people with stroke (Lord
2004). The reported paucity of standing and walking practice in
the early phase after stroke potentially limits the opportunities of
people with stroke to optimise functional recovery, particularly for
standing and walking goals. Further, physical inactivity may lead
to an increased risk of hospital-acquired complications, such as
pressure ulcers, pneumonia, and cardiac compromise (Lindgren
2004).
Physical activity levels of people with stroke remain lower than
their age-matched counterparts, even when they return to living
in the community (English 2016). Community-dwelling stroke
survivors spend the vastmajority of their waking time sitting down
(English 2014). In addition to overcoming the sedentary lifestyles
and habits prevalent in many modern societies, people with stroke
have additional barriers to physical activity, such as muscle weak-
ness, sensory dysfunction, reduced balance, and fatigue (Billinger
2014). However, early research suggests that increasing physical
activity in people with stroke is feasible, and an increase in physical
activity levels after stroke may have a positive impact on fatigue,
mood, community participation, and quality of life (QoL; Graven
2011; Duncan 2015).
Description of the intervention
For this review, we considered an activity monitor to be any wear-
able or portable electronic device that provided feedback (in either
real time, or on a regular basis, e.g. daily or weekly) on physical
activity. People with stroke could use activity monitors indepen-
dently, or as an adjunct to therapy. Activity monitors included
accelerometers and physical activity applications, which may have
been combined with global positioning systems (GPS). Feedback
from a physical activity monitor could have included objective
measures of activity (e.g. step count, time spent in moderate in-
tensity activity), graphs of daily activity, or encouragement on ac-
tivity goals (e.g. encouragement to reach 10,000 steps per day).
Accelerometers are non-invasive activity monitors that record ’ac-
tivity counts’, based on acceleration detected across various move-
ment planes (e.g. X, Y, Z planes). The objective measures of ac-
tivity provided by accelerometers are dependent on the individ-
ual device, and include step count, activity duration, total activ-
ity counts, and energy expenditure. Accelerometers are classified
as ’uniaxial’, ’biaxial’, or ’triaxial’, depending on the number of
movement planes across which they detect acceleration. Exam-
ples of accelerometers include Fitbit Charge HR, Actigraph, and
Sensewear Armband.
Physical activity applications are typically installed on mobile
smart devices, which contain powerful embedded sensors, includ-
ing triaxial accelerometers, GPS, cameras, orientation sensors, and
gyroscopes that can be used to deliver continuous and automated
real time data tomeasure and interpret physical activity (Bort-Roig
2014). Applications downloaded on smart devices feature real time
feedback based on the user’s activity profile, and some applications
include an immersive storyline to engage the user in physical ac-
tivity (Higgins 2016). Illustrations and animations are commonly
used to describe how an activity or exercise is to be correctly per-
formed, and some devices can be paired with wearable devices
to further enhance the experience and data generated (Higgins
2016). Examples of physical activity applications include Strava
Running, Runkeeper, and Fitbit.
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GPS technology is now built into many mobile phones, as well as
wearable physical activity monitors, and measures activity based
on the location of the person. Examples of physical activity GPS
systems are Garmin Forerunner and GlobalSat GPS watches.
How the intervention might work
Activity monitors are inexpensive and readily available to the pub-
lic. They provide users with easy-to-understand, timely, and con-
textually relevant information about their physical activity be-
haviours. Further, many physical activity monitors have been de-
signed to set goals and provide rewards, which are important
elements in changing (and maintaining a change in) behaviour
(Glynn 2013). Some applications have been designed to act as ’vir-
tual coaches’, to encourage and inspire the user. In addition, the
capacity for the user’s behaviour to be shared via the connectivity
capabilities of smart devices can promote social support, feedback,
and competition via social networking platforms (Nakhasi 2014).
Meta-analyses have shown that activity monitors can positively
influence multiple health behaviours, including physical activity
(Fanning 2012).
Activity monitors are increasingly being used to study physical
activity in stroke survivors (Fini 2015). Use of these devices has the
potential to be a relatively cheap and easy method of motivating
people with stroke, both in the clinical and community setting,
to increase physical activity levels for the purposes of maximising
poststroke physical function (e.g. walking), and reducing the risk
of recurrent stroke via regular exercise.
Why it is important to do this review
Despite the benefits of time spent in physical activity poststroke,
people who have had a stroke spend the majority of their day inac-
tive, regardless of time or setting poststroke (Fini 2017). Commer-
cially available, wearable activity monitoring devices and smart-
phone applications provide immediate feedback to users on their
physical activity levels, and if found to be effective in increas-
ing physical activity, have the potential to benefit all people with
stroke. Understanding how effective such devices are in increas-
ing physical activity after stroke will be useful for clinicians and
researchers working in stroke prevention and rehabilitation, and
for people with stroke who would like to improve their physical
activity levels and general well-being.
It is not yet understood whether physical activity monitors alone
or with therapist support are effective and feasible in increasing
physical activity after stroke. Further, we need to investigate the
characteristics of people with stroke (e.g. age, stroke severity) that
may influence a person’s ability to use an activity monitor inde-
pendently, or to engage in behaviour change in response to ac-
tivity monitor feedback. Finally, we need to determine factors re-
lated to the activity monitor intervention, such as type of monitor,
setting, duration of intervention, intensity, dose, frequency, and
mode of feedback for optimum improvements in physical activity
after stroke.
O B J E C T I V E S
To summarise the available evidence regarding the effectiveness
of commercially available, wearable activity monitors and smart-
phone applications for increasing physical activity levels in people
with stroke.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and randomised
cross-over trials.
Types of participants
Participants were adults (aged 18 and over) with a diagnosis of
stroke, who were in a hospital settings or living in the community.
Types of interventions
We included interventions that examined the effectiveness or fea-
sibility of the use of activity monitors for increasing physical ac-
tivity levels within hospital or community settings. We excluded
upper limb activity monitor interventions that were designed to
measure or increase upper limb activity.
We collected data about the type and frequency of feedback de-
livered during the intervention (including whether the timing of
feedback was pre-set or could be controlled by participants), the
duration of intervention, and the type of activity monitor used.
We included studies that compared the use of:
• activity monitor versus no intervention;
• activity monitor versus other intervention;
• activity monitor versus different activity monitor;
• activity monitor plus another intervention (e.g. a prescribed
exercise programme) versus the other intervention alone.
We excluded studies that compared the use of activity monitor
plus another intervention versus no treatment if we could not de-
termine the independent effect of the activity monitor interven-
tion. Given the aim of the review was to determine the effect of
physical activity monitors on promoting activity after stroke, we
excluded studies that used an activity monitor solely as a research
measurement tool.
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Types of outcome measures
Primary outcomes
• Steps per day. Steps per day is relevant to people with stroke
because it is associated with the Activities and Participation
domains of the International Classification of Functioning (Eng
2007).
• Time spent in moderate-to-vigorous intensity physical
activity (MVPA) at the end of the intervention period (short-
term), three months post-intervention (medium-term), and 12
months post-intervention (long-term). We had planned to
measure time in MVPA in minutes per day and in percentage of
waking hours. We had planned to include two methods of
calculating MVPA with devices:
◦ using metabolic equivalents (METS), with MVPA
defined as 3 METS or greater, where 1 MET was defined as the
energy cost of sitting quietly (Haskell 2007);
◦ using activity count cutoff points: for example, 1952
counts per minute or greater (using the equations from Freedson
and colleagues; Freedson 1998).
Time in MVPA is important because MVPA has a vital role in the
prevention of cardiovascular disease and stroke (Tremblay 2010;
McDonnell 2013; Billinger 2014). Further, MVPA is inversely as-
sociated with all-cause mortality in men and women, after adjust-
ment for other demographic and behavioural risk factors (Nocon
2008; Löllgen 2009; Woodcock 2011). Achieving a total physical
activity level of 150 minutes per week of MVPA has been associ-
ated with a relative risk reduction (RRR) in all-cause mortality of
16%; a RRR of 26% was reported for the higher threshold of 300
minutes of MVPA per week (Samitz 2011). Current guidelines
recommend that stroke survivors complete at least 150 minutes
per week of MVPA (Billinger 2014).
Secondary outcomes
Other objective measures of physical activity as secondary out-
comes were:
• sedentary time (measured in minutes per day and
percentage of waking hours);
• time spent in light-intensity physical activity (measured in
minutes per day and percentage of waking hours);
• walking duration (measured in minutes per day and
percentage of waking hours).
These measures can assist in providing a complete picture of phys-
ical activity, and include measures of intensity, frequency, and du-
ration (Fini 2015).
We also included self-reported measures of physical activity levels
as secondary outcomes, in terms of type of activity and context in
which the activity was undertaken.
Additional secondary outcomes included:
• fatigue (e.g. Fatigue Assessment Scale and Fatigue Severity
Scale);
• mood (e.g. Hospital Anxiety and Depression Scale, General
Health Questionnaire-12 Item, Brief Assessment Schedule
Depression Cards, Patient Health Questionnaire-9 item);
• quality of life (QoL; e.g. Stroke Specific Quality of Life
Scale, Stroke Impact Scale-16, EuroQol);
• community participation (e.g. World Health Organization
(WHO) Disability Assessment Schedule);
• adverse events, such as falls, hospitalisations, and death.
Fatigue, mood, QoL, and community participation are altered
following stroke, and an increase in physical activity may have
a positive impact on these factors (Hackett 2005; Graven 2011;
Duncan 2015).
Search methods for identification of studies
See the ’Specialized register’ section in the Cochrane Stroke Group
module. We searched for trials in all languages and planned to
arrange for translation of relevant articles where necessary.
Electronic searches
We searched the following databases:
• Cochrane Stroke Group Trials Register (last searched 3
March 2018);
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 2) in the Cochrane Library (last
searched 3 March 2018; Appendix 1);
• MEDLINE Ovid (1946 to 3 March 2018; Appendix 2);
• Embase Ovid (1980 to 3 March 2018; Appendix 3)
• CINAHL EBSCO (Cumulative Index to Nursing and
Allied Health Literature; 1982 to 3 March 2018; Appendix 4);
• SPORTDiscus EBSCO (1949 to 3 March 2018; Appendix
5).
We developed the MEDLINE search strategy with the help of the
Cochrane Stroke Group Information Specialist, and adapted it for
the other databases (Appendix 2). We placed no search limitations
on language or type of publication.
In addition, we searched the following trial registers, using iden-
tical search terms (Appendix 6):
• WHO International Clinical Trials Registry Platform (
www.who.int/ictrp/en/; searched 3 March 2018);
• Clinicaltrials.gov ( www.clinicaltrials.gov; searched 3 March
2018);
• EU Clinical Trial Register ( www.clinicaltrialsregister.eu;
searched 3 March 2018);
• ISRCTN Registry ( www.isrctn.com; searched 3 March
2018);
• Australian and New Zealand Clinical Trial Registry (
www.anzctr.org.au; searched 3 March 2018);
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• Stroke Trials Registry ( www.strokecenter.org/trials;
searched 3 March 2018).
Searching other resources
To identify any further published, unpublished, or ongoing trials,
we:
• searched the reference lists of relevant articles, and used the
Web of Science Cited Reference Search for forward tracking of
references;
• searched Google Scholar ( scholar.google.com), using the
terms stroke AND (activity monitor or pedometer or
accelerometer); we reviewed the first 200 results; and
• attempted to contact trial authors to obtain further data
where required.
Data collection and analysis
Selection of studies
All review authors independently screened titles and abstracts
of the references obtained from the database searches and other
searching activities, and excluded obviously irrelevant reports. For
the remaining references, we retrieved full-text articles, which at
least two review authors (LJ, NF, MC, DS, HJ, EL, TJ) indepen-
dently screened to determine eligibility, and noted reasons for ex-
clusion. The two review authors resolved disagreements through
discussion, and consulted with a third review author as required.
We recorded the selection process and presented it in a PRISMA
flow diagram (Figure 1).
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Figure 1. PRISMA flow diagram
Data extraction and management
Review authors (TJ, KB, SKr, EL) independently extracted data
from included studies and recorded information on a data extrac-
tion template in Covidence, developed specifically for this study.
We extracted the following data: type of study, participant popu-
lation, study setting, details of interventions and co-interventions,
time frame, and details of outcomes and their definitions. We used
headings from the TIDieR checklist to guide the extraction of data
about the interventions and co-interventions (Hoffmann 2014).
We compared the extracted data and resolved any discrepancies
by discussion; EL checked as required.
Assessment of risk of bias in included studies
Review authors (TJ, SKr, LJ, EL) independently assessed risk of
bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
The two review authors resolved disagreements by discussion, or
by consulting with a third review author (EL).We assessed the risk
of bias according to the following criteria:
• Random sequence generation;
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• Allocation concealment;
• Blinding of participants and personnel;
• Blinding of outcome assessment;
• Incomplete outcome data;
• Selective outcome reporting;
• Other bias (e.g. carryover bias in cross-over trials,
contamination between groups).
We graded the risk of bias for each domain as high, low, or un-
clear. A grading of low risk of bias indicated that the study ap-
peared to be free from bias for the domain. We graded a criterion
as having an unclear risk of bias when there was insufficient infor-
mation available to determine whether an important risk of bias
was present, or there was a lack of clarity whether an identified
problem introduced bias. When there was at least one important
risk of bias for a domain, we identified the domain as having a
high risk of bias: Figure 2 and Figure 3 presents risks of bias of the
included studies.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Measures of treatment effect
We expressed continuous data as mean differences (MDs) with
95% confidence intervals (CIs) for data measured in the same
way between trials, or as standardised mean differences (SMDs)
with 95% CIs to combine data when different scales were used to
measure the same concept. We expressed dichotomous data as risk
ratios (RRs) with 95% CI.
Unit of analysis issues
We only identified individually randomised trials for this review,
so we did not need to analyse for unit of analysis issues, as planned
in our protocol (Lynch 2017).
Dealing with missing data
We followed the methods for sensitivity analysis described in the
Cochrane Handbook for Systematic Reviews of Interventions for deal-
ing with missing data ( Higgins 2011). We assessed and reported
dropout rates for each study, and we used the principle of inten-
tion-to-treat analyses (analysis of all participant data according
to group allocation). We considered the amount of missing data
when determining risk of bias within included studies.
Assessment of heterogeneity
We visually inspected the forest plots for any evidence of hetero-
geneity and used the I² statistic to measure heterogeneity for the
one outcome for which we conducted a meta-analysis (steps per
day). An I² statistic of 50% or higher indicated moderate to sub-
stantial heterogeneity.
Assessment of reporting biases
We had intended to use funnel plots to assess reporting bias, but
we were unable to conduct an assessment of reporting biases (such
as publication bias) due to the small number of included studies.
Data synthesis
We had planned that when there were two or more studies that
were similar in terms of participant population and intervention
received, we would conduct a meta-analysis by pooling the ap-
propriate data using Review Manager 5 (RevMan 2014). We de-
cided not to pool data from different settings (inpatient setting
versus community setting). Given that only two studies collected
the same outcome measure with similar participants, only data
regarding steps per day (in hospital setting) could be pooled. We
described the rest of the findings narratively.
Subgroup analysis and investigation of heterogeneity
We did not perform the planned additional subgroup analysis
(listed below) due to a lack of available data.
• Setting (hospital or community)
• Type of activity monitor (similar pedometer versus more
complex body worn activity monitor)
• Frequency of feedback (real time versus provided at regular
intervals)
• Participant-specific factors (to facilitate identification of
people with stroke most likely to respond to activity monitor
interventions):
◦ age 18 to 64 years, 65 years and over;
◦ walking ability (independent or requiring assistance);
◦ time since stroke (within one month, between one and
six months, more than six months);
◦ gait speed;
◦ gait endurance.
Sensitivity analysis
We judged the strength of each study’s methods using Cochrane’s
tool for assessing risk of bias (Higgins 2011). We had planned to
perform sensitivity analyses to assess the robustness of the findings
by excluding studies from the analysis that were at high risk of
bias (Lynch 2017). However, we did not perform our planned
sensitivity analyses because we were only able to pool data on one
outcome measure from two studies.
GRADE assessment and ’Summary of findings’ table
We presented the main results of the review in Summary of find-
ings tables: Summary of findings for the main comparison, which
includes outcomes for community dwelling stroke survivors, and
Summary of findings 2, which includes outcomes for participants
undergoing inpatient rehabilitation. The tables are for the com-
parison of activity monitor plus another intervention versus other
intervention alone for the primary outcomes of steps per day and
time spent in moderate and vigorous physical activity, and the sec-
ondary outcomes of sedentary time, time spent in light physical
activity and walking duration ( rather than the other six secondary
outcomes) because these align closely with the definition of physi-
cal activity. Two review authors ( KB and SKr) independently rated
the quality of the evidence provided by the studies that contributed
data to the meta-analyses for each outcome using the GRADE
approach ( www.gradeworkinggroup.org/) and GRADEproGTD
software (GRADEpro GDT 2015). The footnotes and comments
sections contain the justification for all decisions to downgrade or
upgrade the quality of studies.
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R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies
Results of the search
We identified a total of 28,098 references from our searching ac-
tivities, and removed 8549 duplicates. We screened the titles and
abstracts of the remaining 19,549 references and excluded 19,520
references. We retrieved 29 articles in full, excluded 10 references,
and identified six ongoing studies (eight references). We included
four studies (11 articles, 245 participants) in the review (Figure
1).
Included studies
The four included trials involving 245 participants, were pub-
lished between 2015 and 2018 in Canada (Mansfield 2015), the
USA (Dorsch 2015; Danks 2016), and Japan (Kanai 2018). Sam-
ple sizes ranged from 27 (13 and 14 in each group; Danks 2016),
to 135 (63 and 72 in each group; Dorsch 2015). The median
age of participants ranged from 58 (Danks 2016), to 66 years
(Dorsch 2015). Time poststroke varied between studies: Kanai
2018 recruited participants within one week of admission to hos-
pital after stroke; Dorsch 2015 and Mansfield 2015 investigated
participants between one to three months poststroke, whereas the
participants in Danks 2016 were in the chronic phase poststroke
(median 51 months). Studies were conducted in inpatient (acute
hospital or rehabilitation) settings (Dorsch 2015;Mansfield 2015;
Kanai 2018), and a university-based laboratory (Danks 2016).
Stroke severity scores ranged from a median of one (Mansfield
2015; Kanai 2018), to six (Dorsch 2015), on the National Insti-
tutes of Health Stroke Scale (NIHSS) and was not reported in
Danks 2016. We contacted the authors of Danks 2016 for this
information, but did not receive a reply.
Participants
Participants in each of the studies needed to be able to commu-
nicate with investigators (Mansfield 2015; Danks 2016), follow
two-stage commands (Dorsch 2015), or not have a diagnosis of
dementia or aphasia (Kanai 2018). All participants were able to
ambulate to varying degrees: in the study by Dorsch 2015, partic-
ipants needed to be able to walk five steps within 10 days of reha-
bilitation admission; and in the studies byMansfield 2015, Danks
2016, and Kanai 2018, participants needed to be able to walk
without supervision or assistance (and without an aid in Kanai
2018).
Interventions
The interventions all involved the use of activitymonitors and pro-
vision of feedback on physical activity. Activity monitors usedwere
triaxial accelerometers (Gulf Coast Data Concepts) worn with one
sensor on each ankle (Dorsch 2015), one sensor on each limb
(Mansfield 2015), Fitbit One (Kanai 2018), and the StepWatch
activity monitor (Danks 2016). In Danks 2016, the intervention
was fast-walking training plus using the StepWatch activity moni-
tor to measure step counts versus fast-walking training alone. The
fast-walking training consisted of 20 minutes on a treadmill in a
harness followed by 10 minutes of overground walking, aiming to
walk at a target heart rate. The aim of the step-activity monitoring
was to increase the daily step count by 8% if the step count was
less than 5000 steps per day, 5% if between 5001 and 7499 steps
per day, or 3% if between 7500 to 9999 steps per day. The inter-
vention in Dorsch 2015 was feedback on speed of walking versus
feedback on speed of walking plus daily feedback from the phys-
iotherapist regarding step count, the average and maximum walk-
ing speed, and the distance walked. The intervention inMansfield
2015 consisted of one hour per day of physiotherapy with goal
setting versus one hour per day of physiotherapy with goal setting
and daily feedback on walking activity. The intervention in Kanai
2018 consisted of goal setting and feedback on steps per day in
addition to supervised occupational therapy and physical therapy
versus supervised occupational therapy and physical therapy only.
The duration of the interventions were three times per week over
12 weeks in Danks 2016, during the inpatient rehabilitation stay
(mean 11 to 12 days in Kanai 2018, or median 22 days in Dorsch
2015), and during the inpatient rehabilitation stay, starting when
participants met eligibility criteria (median 14 days) in Mansfield
2015.
Outcomes
Many different outcomes were measured: steps per day (Mansfield
2015; Danks 2016; Kanai 2018), time spent in light, moder-
ate, and vigorous physical activity (Kanai 2018), total time spent
walking (Danks 2016), Stroke Impact Scale-16 (SIS-16; Dorsch
2015), self-selectedwalking speed (Mansfield 2015; Danks 2016),
6-Minute Walk Test (Danks 2016), maximal walking speed over
10 metres (Danks 2016), 3-Minute Walk Test (Dorsch 2015), 15-
metre walking speed (Dorsch 2015), time spent in two minutes or
more walking bouts (Dorsch 2015), number of walking bouts of
more than five minutes duration (Mansfield 2015), longest bout
duration (Mansfield 2015), energy expenditure (Kanai 2018),
Functional AmbulationCategory (Dorsch 2015), average cadence,
step-length symmetry, swing-time symmetry, step-length variabil-
ity, step-time variability, step-width variability (Mansfield 2015),
stroke self-efficacy score (Mansfield 2015), and self-efficacy for
physical activity score (Kanai 2018). Dorsch 2015 collected data
on walking time per day over the course of the trial, rather than at
the end of the intervention. The study authors did not respond to
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emailed queries regarding availability of end-of-intervention data,
so these data were not included in the analysis. Table 1 presents
the outcomes reported in the included studies mapped to the out-
comes of interest for this review (Lynch 2017).
Excluded studies
We excluded the 10 publications for a variety of reasons, including
wrong study design and wrong comparator. See Characteristics
of excluded studies for individual reasons for exclusions.
Ongoing studies
We identified six ongoing studies in eight publications. See
Characteristics of ongoing studies.
Risk of bias in included studies
Figure 2 summarises the trials, together with risk of bias in the
seven domains. The most prevalent risk of bias was in the area of
performance bias, which was always rated as high risk due to the
inability to blind therapists and participants. Figure 3 shows the
risk of bias in each of the included trials individually.
Allocation
In one of the four studies, the generation technique of the ran-
dom sequence and details regarding allocation concealment were
not reported (Danks 2016). Authors did not respond to emailed
queries regarding them, so we deemed this study’s risk of selec-
tion bias to be unclear. The remaining three studies adequately
described the randomisation technique and concealed allocation
process, and we deemed the risk of selection bias for these studies
to be low.
Blinding
Blinding was not possible for personnel (therapists) in any of the
studies, and was either not possible or unclear for participants, so
we judged the risk of performance bias to be high in all included
studies. All studies reported blinding of outcome assessment ex-
cept Kanai 2018, where data for three of the four outcome mea-
sures were downloaded from the accelerometer, and self-efficacy
was collected by physiotherapists who were not blinded to partic-
ipants’ group allocation. We judged all studies to have a low risk
of detection bias.
Incomplete outcome data
There was some participant attrition in all four included studies.
However, all participants were accounted for in all papers, with
reasons for attrition clearly provided. The proportion of partic-
ipants with complete outcome data was greater than 80% in all
papers. Therefore, we deemed the risk of bias due to incomplete
outcome data to be low.
Selective reporting
Two of the four included studies published study protocols
(Dorsch 2015; Mansfield 2015), whilst all papers published all
predefined study outcomes. Therefore, we judged all four included
papers to have a low risk of reporting bias.
Other potential sources of bias
We did not identify any other potential sources of bias.
Effects of interventions
See: Summary of findings for the main comparison Activity
monitor plus other intervention compared to other intervention
alone for increasing physical activity in adult community dwelling
stroke survivors; Summary of findings 2 Activity monitor
plus other intervention compared to other intervention alone
for increasing physical activity in adult stroke survivors during
inpatient rehabilitation
See Summary of findings for the main comparison (community
dwelling stroke survivors) and Summary of findings 2 (stroke sur-
vivors participating in inpatient rehabilitation) for the main com-
parison of activity monitor plus another intervention versus other
intervention alone for increasing physical activity in adult stroke
survivors. The summary of findings tables present our primary
outcome measures and secondary outcomes that align with physi-
cal activity (i.e. sedentary time, time spent in light intensity phys-
ical activity and walking duration). None of the included studies
reported or measured our primary outcome measure of time spent
in MVPA or our secondary outcome measures of sedentary time,
self-reported physical activity, fatigue, mood, community partici-
pation, adverse events, or death.
Primary outcomes
Steps per day
Three studies (110 participants) measured physical activity using
steps per day (Mansfield 2015; Danks 2016; Kanai 2018). The
participant populations were different between the three studies
(one study included people living in community, and two studies
included people participating in inpatient rehabilitation). There
was no significant difference in steps per day between groups for
the study conducted in a community setting by Danks 2016 (MD
-1.93, 95% CI -4.41 to 0.55; 27 participants). Using the GRADE
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criteria, we assessed the quality of evidence for the outcome steps
per day in community dwelling stroke survivors as very low due
to the lack of blinding of participants and personnel and the small
sample size. As presented in Analysis 1.1, whenwe pooled data col-
lected from people participating in inpatient rehabilitation, there
was no significant difference in steps per day between groups (mean
difference (MD) 1.40 steps (x1000), 95% confidence intervals
(CI) -0.04 to 2.84; two RCTs, 83 participants). The I² statistic
was 65%, indicating substantial heterogeneity between these two
studies. We assessed the quality of evidence for the outcome steps
per day in inpatient rehabilitation as very low using GRADE cri-
teria based on the lack of blinding, lack of information regarding
the randomisation procedure, the small sample size and hetero-
geneity.
Time spent in moderate-to-vigorous intensity physical
activity (MVPA)
No studies reported time in MVPA. One study (48 partici-
pants participating in inpatient rehabilitation) presented data
separately for moderate-intensity and vigorous-intensity activity
(Kanai 2018). At the end of the intervention period, time in mod-
erate-intensity activity was significantly higher in the activitymon-
itor group compared with usual rehabilitation (MD 4.40, 95%
CI 0.28 to 8.52), but time in vigorous-intensity activity was not
significantly different between groups (MD 2.60, 95% CI -0.80
to 6.00). Regardless of group allocation, the time spent in mod-
erate-intensity activity was very low (2.7 minutes per day versus
7.1 minutes per day). Analysis 1.2 presents data regarding time
in moderate, vigorous and light physical activity, the evidence for
these outcomes was low as it was based on a small study in which
personnel and participants were not blinded.
Secondary outcomes
Sedentary time
None of the four included studies reported measures of sedentary
time.
Time spent in light intensity physical activity
One study (48 participants) reported time spent in light-intensity
physical activity (Kanai 2018) during inpatient rehabilitation. At
the end of the intervention period, time in light-intensity phys-
ical activity was significantly higher in the group assigned to use
activity monitors (MD 25.80 minutes, 95% CI 0.48 to 51.12),
as illustrated in Analysis 1.2. We rated the quality of evidence as
low using GRADE criteria due to the small number and lack of
blinding of participants.
Walking duration
Two studies (62 participants) measured total walking time at the
end of the intervention period (Mansfield 2015; Danks 2016).
The participant populations were different between the two stud-
ies (people in inpatient rehabilitation and people living in the com-
munity) so we did not pool the data, but presented them sepa-
rately in Analysis 1.3. There was no significant difference in total
walking time between groups in either study. We rated the quality
of evidence for inpatient rehabilitation and community dwelling
stroke survivor studies as low using the GRADE criteria due to
the small number and lack of blinding of participants.
Fatigue
None of the four included studies reported measures of fatigue.
Mood
None of the four included studies reported measures of mood.
Quality of life (QoL)
One study (135 participants) measured QoL using the SIS-16
(Dorsch 2015). At the end of the intervention period, QoL was
not significantly different between groups. We rated the quality
of evidence as low, because participants and personnel were not
blinded, and the confidence interval was wide, spanning both a
positive effect as well as a negative effect of the intervention.
Community participation
None of the four included studies reported measures of commu-
nity participation
Adverse events
None of the four included studies reported measures of adverse
events such as falls, hospitalisations, or death.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Activity monitor plus other intervention compared to other intervention alone for increasing physical activity in adult stroke survivors during inpatient rehabilitation
Patient or population: increasing physical act ivity in adult stroke survivors during inpat ient rehabilitat ion
Setting: inpat ient rehabilitat ion
Intervention: act ivity monitor plus other intervent ion
Comparison: other intervent ion alone
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with other inter-
vention alone
Risk with Activity mon-
itor plus other inter-
vention
Number of steps per
day (x 1000) at end
of intervent ion (< 6
months post-stroke)
The mean number of
steps per day (x 1000)
at end of intervent ion (<
6 months post-stroke)
was 3.1 steps (x 1000)
MD 1.4 steps (x 1000)
higher
(0.04 lower to 2.84
higher)
- 83
(2 RCTs)
⊕©©©
Very low 123
Based on 2 small stud-
ies with heterogeneous
results in which pa-
t ients and personnel
were not blinded and
lim ited information was
provided about ran-
domisat ion and alloca-
t ion procedures
Time spent in MVPA
(minutes) at the end
of the intervent ion (<
6 months post-stroke) -
not reported
- - - - -
Sedentary t ime (min-
utes) at the end of
the intervent ion (< 6
months post-stroke) -
not reported
- - - - -
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Time spent on light in-
tensity physical act iv-
ity (m inutes) at the end
of the intervent ion (<
6 months post-stroke)
(Time spent on light in-
tensity physical act ivity
(m inutes) )
The mean time spent
on light intensity physi-
cal act ivity (m inutes) at
the end of the interven-
t ion (< 6 months post-
stroke) was 113.7 min/
day
MD 25.8 min/ day higher
(0.48 higher to 51.1
higher)
- 48
(1 RCT)
⊕⊕©©
Low 13
Based on a single small
study in which part ic-
ipants and personnel
were not blinded
Total t ime walking
(minutes) at end of in-
tervent ion (< 6 months
post-stroke)
The mean total t ime
walking (minutes) at
end of intervent ion (<
6 months post-stroke)
was 71.5 min/ day
MD 4.4 min/ day higher
(11.52 lower to 20.32
higher)
- 35
(1 RCT)
⊕⊕©©
Low 13
Based on a single small
study in which part ic-
ipants and personnel
were not blinded
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High certainty: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Risk of bias: part icipants and personnel were not blinded
2 Heterogeneity: the I-squared stat ist ic suggest that substant ial heterogeneity might be present
3 Imprecision: the study included a small sample and conf idence intervals were wide
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D I S C U S S I O N
Summary of main results
The primary aim of this review was to determine if activity mon-
itors were effective in increasing physical activity levels of people
with stroke. There is very low-qualityevidence that interventions
that used activity monitors in conjunction with another interven-
tionmay not have an effect on step counts for community dwelling
stroke survivors or during inpatient rehabilitation. None of the
studies reported time spent on MVPA.
One study explored the effect of fast-walking training with step-
activity monitoring on daily step count and measures of walking
ability (Danks 2016). Another study reported on the effect of feed-
back on walking speed and walking activity on time spent walking
per day and walking ability (Dorsch 2015). Two studies reported
on the effect of daily feedback on physical activity in addition
to usual inpatient rehabilitation on daily step counts, along with
other measures of mobility and activity (Mansfield 2015; Kanai
2018). Three of the four studies reported on our primary outcome
measure of step count at the end of the intervention, and only one
study reported on our primary outcome measure of time spent
in moderate-intensity activity. Overall, we observed no significant
effect for interventions that used activity monitors in conjunction
with another intervention on step counts in people with stroke
(mean difference (MD) in inpatient setting 1400 more steps, 95%
CI -40 to 2840; MD in community setting: 1930 fewer steps,
95% CI -4410 to 550). One small study showed that use of activ-
ity monitors had a significant effect on time spent in moderate-
intensity physical activity but no significant effect on time spent
in vigorous-intensity physical activity for people in inpatient set-
tings (MD in time spent in moderate-intensity activity in inpa-
tient setting 4.4 minutes longer, 95% CI 0.28 to 8.52; MD in
time spent in vigorous-intensity activity in inpatient setting 2.6
minutes longer, 95% CI -0.8 to 6).
Overall completeness and applicability of
evidence
Research regarding the use of wearable activity monitors is in its
infancy, but with six ongoing studies identified, the momentum
of this field of research is growing. We included four small RCTs
that were conducted in different settings (inpatient rehabilitation
and community) with people of different walking abilities. Three
of the four included studies used research-grade activity monitors
(StepWatch activity monitor and Gulf Coast Data Concepts tri-
axial accelerometer); only one study used an activity monitor de-
signed for use by consumers (Fitbit One) in the interventions. No
consistent outcome measure was used in all four studies, which
limited our ability to pool the available data. Therefore, our ability
to reach generalisable conclusions relating to the effect of activity
monitors to improve physical activity in people with stroke was
limited. The issue of a lack of commonality in outcome measures
in stroke rehabilitation research has been noted previously, leading
to the development, by a group of international stroke research ex-
perts, of consensus-based core recommendations to measure sen-
sorimotor recovery in future stroke rehabilitation trials (Kwakkel
2017).
Overall, the four included studies did not find a beneficial effect
from the addition of activity monitors to other interventions on
most of our outcomes, with the exception of light- and moder-
ate-intensity physical activity, which were measured in only one
study. It is important to consider that there are many factors that
contribute to reduced activity levels after stroke, such as physical
disability, fear of falling, a lack of understanding about what ac-
tivity is allowed or safe after stroke, and sedentary lifestyle habits
(Nicholson 2013; English 2016b). Activity monitors are likely to
be most effective in changing activity levels when they are incor-
porated as a tool in a multifaceted behaviour change intervention,
which address pertinent factors that inhibit activity levels.
Quality of the evidence
Overall, the quality of the evidence was low to very low according
to GRADE criteria, due to the small number of trials and sample
sizes included in the review, which led to confidence intervals for
six of the eight included outcomes reporting both positive and
negative effects of the activity monitor intervention, and the high
risk of performance and detection bias in the included studies.
There was very low-quality evidence for the number of steps per
day in inpatient settings, time spent in vigorous-intensity physical
activity, and total time spent walking in inpatient rehabilitation
and community settings.The true effect may be substantially dif-
ferent from the estimate of effect.
There was very low-quality evidence for steps per day in commu-
nity settings. We have very little confidence in this effect estimate,
the true effect is likely to be substantially different from the esti-
mate of effect.
There was low-quality evidence for time spent in low,- moderate-
and vigorous intensity physical activity. We have limited confi-
dence in the effect, the true effect may be substantially different
from the estimate of the effect.
Potential biases in the review process
While our literature search was extensive, there remains a risk of
selection bias. We attempted to reduce potential bias by having
two review authors screen studies for inclusion eligibility, and we
resolved discrepancies in collaboration with a third review author
if the original two review authors could not achieve consensus.
Two review authors independently extracted data and assessed risk
of bias of the included studies, with discrepancies resolved by con-
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sensus or with another review author. However, subjective judge-
ments were required during the review process, and a different
review team may judge risk of bias differently.
Agreements and disagreements with other
studies or reviews
The findings from this review are different from previous reports
in other populations regarding the effectiveness of activity mon-
itors to increase physical activity. Activity monitors and mobile
applications have been used to increase physical activity in healthy
adults (Kirwan 2012; Finkelstein 2016), hospitalised adults under-
going cardiac rehabilitation (Izawa 2012), and overweight adults
(de Vries 2016), with good effect. However, often these are used in
combination with a behaviour change intervention (Izawa 2012;
de Vries 2016), or online programmes that provide information
and support to increase physical activity (Kirwan 2012).
Activity monitor or mobile application interventions that do not
specifically target physical activity goals (e.g. those that target
weight loss, but also measure physical activity) do not lead to in-
creases in physical activity (Mateo 2015). Activity monitor or mo-
bile application interventions that do not incorporate behaviour
change strategies, provide additional information or support to in-
crease physical activity, or specifically target physical activity goals,
have not demonstrated effectiveness in increasing physical activ-
ity levels (Mateo 2015; Finkelstein 2016). In contrast, behaviour
change interventions have demonstrated good potential in increas-
ing physical activity in people with stroke (Jones 2015).
Therefore, it is likely that the lack of consistent effectiveness of
physical activity monitors for increasing physical activity in the
included articles in this review can be explained, at least in part,
by the lack of incorporation of specific behaviour change strate-
gies. One of the most widely used frameworks for understand-
ing and changing behaviour is the COM-B (capability, opportu-
nity, motivation and behaviour) framework and the associated Be-
haviour ChangeWheel (Michie 2011;Michie 2014). The premise
of COM-B is that behaviour is determined by capability, oppor-
tunity, and motivation, so in order to change behaviour, a person’s
capability, opportunity, and motivation to perform that behaviour
need to be addressed. In terms of physical activity after stroke, a
person’s capability to be physically active might be limited due to
physical barriers, such as weakness, pain, reduced balance, or fa-
tigue. Physical capability is typically the focus of physiotherapy in-
terventions; the interventions received by both the treatment and
control groups in all four studies included in this review targeted
physical capability by addressing mobility and independence. Psy-
chological capability encompasses factors such as knowing why
activity is important, and what sort of activities constitute ’phys-
ical activity’. Opportunity includes a safe environment in which
to be active, including the provision of assistance when required,
and support from others, such as peers, health professionals, and
family members to be active. Motivation includes both the desire
to perform physical activity, as well as developing plans and habits
of being active. While the use of activity monitors facilitated feed-
back of current performance, this feedback was not specifically
embedded within a programme that addressed all of the factors
influencing behaviour, mentioned above, in most of the included
studies. The most recent study, which incorporated access to real
time feedback (via a device designed for consumer use) and daily
goal-setting with physiotherapists as part of the intervention, re-
ported the most positive results (Kanai 2018). We hypothesise
that incorporating the use of activity monitors as a tool within a
multifaceted behaviour change intervention may prove to be more
effective in changing physical activity levels in future studies.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The current evidence is insufficient to make a recommendation
about the use of activity monitors for stroke survivors to increase
physical activity in inpatient or community settings. The limited
low to very low quality evidence currently available indicated that
adding the use of activity monitors to general rehabilitation pro-
grammes did not appear to be an effective strategy to increase
physical activity levels, in terms of step counts or levels of MVPA
in people with stroke.
Implications for research
More research investigating the use of activitymonitors is required.
Given the complexity of changing physical activity levels, fur-
ther research is warranted to investigate whether activity monitors
provide added value to structured behaviour modification pro-
grammes aimed at increasing physical activity. No outcome mea-
sure was used in all four included studies, so we recommend that
researchers use consistent outcome measures, as recommended by
Kwakkel 2017, so that data can be compared and pooled across
studies. As recommended by Walker 2017, usual rehabilitation
care should be clearly described to allow comparisons between
studies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Danks 2016
Methods Study design: randomised controlled trial
Study grouping: parallel group
Aim of study: to determine preliminary efficacy and to identify baseline characteristics
predicting who would benefit most from fast-walking training plus a step activity moni-
toring program (FAST + activity monitoring) compared with fast-walking training alone
(FAST) in people with chronic stroke
Unit of allocation: randomised at the individual participant level
Duration of participation: 30 minutes, 3 times per week for 12 weeks (36 sessions)
Ethical approval obtained for study: approved by the Human Subjects Review Board
at the University of Delaware
Blinding: all outcome measurements were performed by a blinded assessor
Physical activity monitor/s used: StepWatch activity monitor
Participants Baseline characteristics
Other intervention alone (FAST-only)
• Age, years: 58.2 ± 12.4
• Sex: 6 women, 8 men
• Side of stroke: 9 left, 5 right
• Time since stroke: 50.8 ± 44.1 months
• Lower Extremity Fugl-Meyer Score (out of 34): 18.6 ± 4.6
Activity monitor plus other intervention (FAST + activity monitoring)
• Age, years: 59.1 ± 8.7
• Sex: 6 women, 7 men
• Side of stroke: 7 left, 6 right
• Time since stroke: 29.4 ± 21.4 months
• Lower Extremity Fugl-Meyer Score (out of 34): 16.8 ± 7.1
Overall
• Age, years: not reported
• Sex: 12 women, 15 men
• Side of stroke: 16 left, 11 right
• Time since stroke: not reported
• Lower Extremity Fugl-Meyer Score (out of 34): not reported
Inclusion criteria: individuals aged 21 to 85 years were included in the study if they (1)
had sustained a stroke > 6 months prior; (2) were able to walk without assistance (the
use of orthotics or assistive devices was allowed); (3) were able to walk 5 minutes at a
self-selected pace on the treadmill; (4) were able to walk outside the home before stroke;
(5) walked less than 10,000 steps per day; and (6) were able to communicate with the
investigators
Exclusion criteria: (1) had experienced > 1 stroke; (2) had evidence of a cerebellar stroke;
(3) had additional neurologic diseases; (4) had a cardiac event within last 3 months; (5)
had received botulinum toxin type A in the lower extremities within past 4 months; (6)
had pain that limited walking; (7) had unexplained dizziness in the past 6 months; or
(8) were participating in skilled physical therapy services
Pretreatment: at baseline, there were no statistically significant differences in age or time
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Danks 2016 (Continued)
since stroke between groups
Setting: university-based laboratory
Method of recruitment of participants: recruited from local physical therapy clinics,
stroke support groups and newspaper advertisements
Informed consent obtained: unclear
Total number randomised: 37 (19 to FAST + activity monitoring; 18 to FAST-only)
Withdrawals and exclusions: 70 assessed for eligibility, 33 excluded (7 did not meet
inclusion criteria, 25 declined to participate, 1 other reason)
FAST+activitymonitoring: 6withdrawals: 2 did not receive intervention because did not
pass cardiac stress test, 4 discontinued intervention (poor attendance n = 1, exacerbation
of pain from previous injury n = 2, seizure requiring hospitalisation n = 1)
FAST-only: 4 withdrawals: 1 did not receive intervention due to fall with fracture prior
to starting, 3 discontinued intervention (poor attendance n = 2, car accident resulting
in fracture n = 1)
Subgroups measured and/or reported: nil
Interventions Intervention characteristics
Other intervention alone (FAST-only)
• Wearing of activity monitor: Stepwatch Activity Monitor worn during all training
sessions for 12 weeks
• Walking training: 30 minute sessions: fast-walking treadmill training programme
(wearing overhead chest harness system, no body weight support provided) followed
directly by 10 minutes of overground walking activities. Participants walked for 30
minutes with the goal of walking at the fast training speed within a target heart rate
(THR), calculated as THR = ([220 - age] - resting heart rate) x 80% resting heart rate
Activity monitor plus other intervention (FAST + activity monitoring)
• Wearing of activity monitor: Stepwatch Activity Monitor worn throughout the
12-week training programme
• Walking training: 30-minute sessions: fast-walking treadmill training programme
(wearing overhead chest harness system, no body weight support provided) followed
directly by 10 minutes of overground walking activities. Participants walked for 30
minutes with the goal of walking at the fast training speed within a target heart rate
(THR), calculated as THR = ([220 - age] - resting heart rate) x 80% resting heart rate
• Activity monitoring program: baseline step activity data were used to categorise
and assign individual participants’ step activity goals. Participants were asked to
increase walking activity by 8% if completing an average of up to 5000 steps/day,
increase walking activity by 5% if averaging between 5000 and 7499 steps/day and
increase walking activity by 3% if averaging between 7500 and 9999 steps/day
• Participants were expected to achieve their daily step goal on the days that they
did not attend treadmill training sessions. For those who were able to attain six days of
goal achievement over a 2-week period, a new activity goal was calculated based on the
average steps/day completed in the second week of the 2-week monitoring period
• Feedback to participants: step activity data (numbers of steps/day on non-
treadmill training days) were reviewed at each treadmill training session and used to
determine and promote goal achievement. An individualised discussion of barriers to
increased activity and how to overcome those barriers occurred at each session
• Additional intervention components: physical therapists discussed specific topics
(e.g. education on the benefits of activity and risks of inactivity, monitoring a sedentary
lifestyle and substituting activity for inactivity) during the 2-week goal advancement
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session
Outcomes Number of steps per day (SPD)
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: daily step counts
• Direction: higher is better
• Data value: endpoint
• Notes: both baseline and endpoint were fully reported
Total time walking (hours)
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: hours
• Direction: higher is better
• Data value: endpoint
• Notes: both baseline and endpoint were fully reported
Self-selected walking speed (SSWS)
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: metres/second
• Direction: higher is better
• Data value: endpoint
• Notes: both baseline and endpoint were fully reported
6-Minute Walk Test (metres)
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: metres
• Direction: higher is better
• Data value: endpoint
• Notes: both baseline and endpoint were fully reported
Maximal walking speed (MWS)
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: metres/second
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: supported by the National Institutes of Health (grant no.
R21HD07142). Publication of article was supported by the American Congress of Re-
habilitation Medicine
Country: USA
Setting: outpatient clinical research laboratory
Comments: participants were recruited from local physical therapy clinics, stroke sup-
port groups, and newspaper advertisements. Participants completed outcome assessment
in a university-based laboratory
Authors name: Darcy S Reisman
Institution: University of Delaware
Email: dreisman@udel.edu
Address: 540 S, College Ave, Newark, DE 19713, USA
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Generation technique of random sequence
was not discussed
Allocation concealment (selection bias) Unclear risk There was no specific discussion regarding
allocation concealment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of personnel not possible and
blinding of participants to true nature of
study was unclear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcomemeasurement testingwas done
by an investigator blinded to group assign-
ment
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants were accounted for, with
none lost to follow-up, reasons were clearly
given as to withdrawal and exclusion from
study
Selective reporting (reporting bias) Low risk Table 2 presented all data in full
Other bias Low risk -
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Methods Study design: randomised controlled trial
Study grouping: parallel group
Aimof study: to test the feasibility of providing quantitative feedback about dailywalking
performance and motivating greater skills practice via remote sensing in inpatient stroke
rehabilitation
Unit of allocation: randomised at the individual participant level, block randomisation
design was used
Duration of participation: commenced participation when met eligibility criteria
(within 10 days of admission) and continued until discharge from inpatient rehabili-
tation. Median trial participation time 20 days in speed-only feedback group and 22.5
days in activity monitor plus speed feedback group
Ethical approval obtained for study: ethical approval was granted by each site’s local in-
stitutional review board. The study was registered at ClinicalTrials.gov (NCT01246882)
Blinding: all outcome measurements were performed by a blinded assessor
Physical activity monitor used: triaxial accelerometers (Gulf Coast Data Concepts,
Waveland, MS) worn with 1 sensor on each ankle
Participants Baseline Characteristics
Other intervention alone (speed-only feedback)
• Age, years: 65.0 ± 13.2
• Sex: 59 women, 92 men
• Stroke type, n (%): large vessel ischaemic 41 (56.2); lacunar 11 (15.0);
haemorrhagic 14 (19.2); unknown 7 (9.6)
• Hemiparetic side, n (%): R 42 (59.2), L 29 (40.8)
• Second stroke, n (%): 4 (5.5)
• Time from stroke to rehabilitation, days, median (Interquartile range, IQR): 8.5
(4.2 to 14.8)
• National Institutes of Health Stroke Scale (NIHSS), median (IQR): 6 (4 to 9)
• Functional Ambulation Classification (FAC) score, n (%): 0: 6 (9.0); 1: 21 (31.2);
2: 20 (30.0); 3: 9 (13.4); 4: 9 (13.4); 5: 2 (3.0)
• 15-metre walk speed, m/s: 0.52 ± 0.47
• 3-minute walk distance, m: 79.7 ± 68.5
• Rehabilitation length of stay, days, median (IQR): 25 (18 to 36.5)
Activity monitor plus other intervention (activity monitoring + speed feedback)
• Age, years: 61.8 ± 15.7
• Women, n (%): 31 (40.3)
• Stroke type, n (%): large vessel ischaemic 45 (57.7); lacunar 18 (23.0);
haemorrhagic 13 (16.7); unknown 2 (2.6)
• Hemiparetic side, n (%): right 44 (56.4), left 34 (43.6)
• Second stroke, n (%): 3 (3.9)
• Time from stroke to rehabilitation, days, median (IQR): 8 (5 to 16)
• NIHSS, median (IQR): 6 (4 to 7)
• FAC score, n (%): 0: 6 (8.2); 1: 28 (38.4); 2: 19 (26.0); 3: 8 (11.0); 4: 7 (9.6); 5:
5 (6.8)
• 15-metre walk speed, m/s: 0.52 ± 0.45
• 3-minute walk distance, m: 80.9 ± 67.5
• Rehabilitation length of stay, days, median (IQR): 25 (17 to 36)
Overall
• Age, years: not reported
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• Women, n (%): 59 (39.1)
• Stroke type, n (%): large vessel ischaemic 86 (57.0); lacunar 29 (19.2);
haemorrhagic 27 (17.9); unknown 9 (6.0)
• Hemiparetic side, n (%): right 86 (57.0); left 63 (41.7)
• Second stroke, n (%): 7 (5.0)
• Time from stroke to rehabilitation, days, median: 9
• NIHSS, median (IQR): 6 (4 to 8)
• FAC score, n (%): 0:12 (8.6); 1:49 (35); 2:39 (27.9); 3:17 (12.1); 4:16 (11.4); 5:7
(5.0)
• 15-metre walk speed, m/s: 0.46
• 3-minute walk distance, m: 85.8
• Rehabilitation length of stay, days, median: 25
Inclusion criteria: people with stroke with residual hemiparesis were eligible if they
could walk 5 steps within 10 days of admission to inpatient rehabilitation, and were
admitted to the inpatient rehabilitation facility within 35 days of stroke. Patients with
previous stroke were eligible to participate if they had experienced full motor recovery
Exclusion criteria: aphasia limiting the ability to follow 2-step commands and ongoing
medical disease limiting participation in physical therapy
Pretreatment: at baseline, there were no statistically significant differences in age, sex,
stroke location, or disability between groups
Setting: inpatient rehabilitation centres: 4 within USA, 12 international
Method of recruitment of participants: recruited from inpatient rehabilitation units -
specific process of recruitment not described
Informed consent obtained: all participants provided written informed consent prior
to participation
Total number randomised: 151 (73 to speed-only feedback, 78 to activity monitoring +
speed feedback), 125 completed study (58 speed-only feedback, 67 activity monitoring
+ speed feedback)
Withdrawals and exclusions: 156 screened for eligibility, 5 excluded (2 with minimal
paresis; 1 with aphasia; 1 with residual deficits from prior stroke; 1 unknown)
Speed-only feedback: 10 received no intervention (n = 10 from SF group; 6 withdrawn
by day 3 admission, 4 admitted > 35 days poststroke), 5 did not complete study (2 cardiac
adverse events, 1 neurologic adverse events, 1 sensor failure, 1 refusal to continue)
Activity monitoring + feedback: 6 received no intervention (5 withdrawn by day 3
admission, 1 admitted > 35 days poststroke), 5 did not complete study (1 unspecified
adverse event, 1 refusal to continue, 1 left hospital against medical advice, 2 unknown)
Subgroups measured, reported, or both: functional impairment groups - based on
mean baseline 15 m walking speed: 0.13 m/s = severely affected, 0.38 m/s = moderately
affected, and 1.12 m/s = mildly affected
Method of randomisation: randomly assigned to a speed-only feedback or speed feed-
back plus activity monitor feedback trial arm by a computer using a concealed allocation
sequence. A block randomisation design was employed to achieve equal group numbers
at each study site
Interventions Intervention characteristics
Other intervention alone
• Speed feedback: accelerometer worn each day from before getting out of bed until
back in bed at end of the day (weekend use was optional). Activity classified and
recorded by gait system. Three times a week after performing a fast 10-metre walk test,
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all participants received standardised verbal feedback, for example, “Very good! You
walked that in (number of ) seconds”
• Participation in trial, days, median (IQR): 20 (14 to 33)
• Days with processed sensor data, days, median (IQR): 10 (7 to 18.5)
• Daily activity monitoring, hours, median (IQR): 8.7 (7.8 to 10.8)
Activity monitor plus other intervention
• Speed feedback: accelerometer worn each day from before getting out of bed until
back in bed at end of the day (weekend use was optional). Activity classified and
recorded by gait system. Three times a week after performing a fast 10-metre walk test,
all participants received standardised verbal feedback, for example, “Very good! You
walked that in (number of ) seconds”
• Intervention programme: personalised bar graphs summarising daily step count,
average and maximum walking speed, and distance walked were reviewed by
participants with the therapists. Using a scripted statement, therapists encouraged these
patients to meet or exceed their prior activity levels. For example “You are showing
some improvement” or “You have not yet increased your (walking speed, distance,
steps), let’s see if you can make further improvements today”
• Participation in trial, days, median (IQR): 22.5 (13.8 to 31)
• Days with processed sensor data, days, median (IQR): 13 (9 to 18.8)
• Daily activity monitoring, hours, median (IQR): 8.7 (7.9 to 9.9)
Outcomes 3-MWT (metres)
• Outcome type: continuous outcome
• Reporting: fully reported
• Scale: distance
• Unit of measure: metres
• Direction: higher is better
• Data value: endpoint
Functional Ambulation Category (FAC)
• Outcome type: dichotomous outcome
• Reporting: fully reported
• Range: 0 to 5
• Unit of measure: ≥ 4
• Direction: higher is better
• Data value: endpoint
• Notes: 0 = nonfunctional ambulation; 1 = manual assistance, heavy; 2 = manual
assistance, light; 3 = stand-by assistance; 4 = assistance for stairs; 5 = independent
Stroke Impact Scale (SIS-16)
• Outcome type: continuous outcome
• Reporting: partially reported
• Range: 16 to 80
• Direction: higher is better
• Data value: endpoint
• Notes: participant perception of function; 16 questions scored from 1 to 5
Total daily walking time (minutes)
• Outcome type: continuous outcome
• Reporting: partially reported
• Unit of measure: minutes
• Direction: higher is better
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• Data value: endpoint
15-metre walking speed
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: metres
• Direction: higher is better
• Data value: endpoint
Time in longer walking bouts (≥ 2 minutes)
• Outcome type: continuous outcome
• Reporting: partially reported
• Scale: time spent in walking in longer bouts (≥ 2 minutes)
• Unit of measure: minutes
• Direction: higher is better
• Data value: endpoint
Identification Sponsorship source: data analysis and support for study co-ordination at Univerisity of
California Los Angeles (UCLA) was partially funded by NIH/NICHD R01 HD07809
to Dr Dobkin and by NIH/NCATS grant UL1TR000124
Country: international - led by American team from UCLA, with 4 centres inside USA
Setting: inpatient rehabilitation setting
Comments: n/a
Authors name: Bruce H Dobkin
Institution: Department of Neurology, Geffen School of Medicine, University of Cali-
fornia Los Angeles
Email: bdobkin@mednet.ucla.edu
Address:Department of Neurology,Geffen School ofMedicine, University of California
Los Angeles, RNRC, Room 1-129, 710 Westwood Plaza, Los Angeles, CA 90095, USA
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “After eligibility criteria were en-
tered into the central database, partici-
pants were assigned to a speed-only feed-
back or augmented feedback trial arm by a
computer using a concealed allocation se-
quence. A block randomization design was
employed to achieve equal group numbers
at each study site.”
Allocation concealment (selection bias) Low risk Concealed allocation sequence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of personnel not possible. Partic-
ipants were fully informed
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded observers collected a stopwatch-
timed 15-metre walk, the distance walked
in 3 minutes, and Functional Ambulation
Category (FAC) score
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants were accounted for, with
none lost to follow-up, reasons were clearly
given as to withdrawal or exclusion from
study
Selective reporting (reporting bias) Low risk All final data reported
Other bias Low risk -
Kanai 2018
Methods Study design: randomised controlled trial
Study grouping: parallel group
Aim of study: to evaluate the effect of accelerometer-based feedback on physical activity
in hospitalised patients with ischaemic stroke
Unit of allocation: randomised at individual participant level
Duration of participation: from enrolment (mean 4 days after admission) until dis-
charge from inpatient rehabilitation. During inpatient stay, received 40 to 120 minutes
of supervised rehabilitation 5 to 6 times/week. Mean length of hospital stay 11 to 12
days
Ethical approval obtained for study: the study was approved by the Itami Kousei
Neurosurgical Hospital Research Ethics Committee (approval no. 20140002)
Blinding: treating therapists were not blinded to patient allocation. Data for 3 of 4
outcomes were collected using objective accelerometer based measure. Fourth outcome
measure collected by physical therapists who were aware of which patients were in the
intervention group and the control group
Physical activity monitor used: Fitbit One
Participants Baseline Characteristics
Other intervention alone (usual inpatient rehabilitation)
• Age, years: 62.9 ± 9.1
• Sex: 12 women, 13 men
• Stroke type, n: large artery atherosclerosis 4; cardioembolic 2; small vessel
occlusion 18; undetermined 1
• Hemiparetic side, n (%): right 11 (44), left 14 (56)
• Time from admission to study enrolment, days: 3.8 ± 1.5
• National institutes of Health Stroke Scale (NIHSS): 1.0 ± 1.0
• Walking speed m/s: 1.1 ± 0.3
• Berg Balance Scale, score: 54.7 ± 1.7
• Length of hospital stay, days: 11.4 ± 3.9
Activity monitor plus other intervention (rehabilitation with accelerometer-based feed-
back)
• Age, years: 66.8 ± 10.0
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• Sex: 8 women, 15 men
• Stroke type, n: large artery atherosclerosis 6; cardioembolic 1; small vessel
occlusion 16
• Hemiparetic side, n (%): right 9 (39.1), left 13 (56.5), bilateral 1 (4.3)
• Time from admission to study enrolment, days: 3.6 ± 1.4
• NIHSS: 0.9 ± 0.8
• Walking speed m/s: 1.1 ± 0.2
• Berg Balance Scale, score: 54.1 ± 2.1
• Length of hospital stay, days:12.2 ± 2.8
Overall
• Age, years: not reported
• Sex: 20 women, 28 men
• Stroke type, n: large artery atherosclerosis 10; cardioembolic 3; small vessel
occlusion 34, undetermined 1
• Hemiparetic side: right 22, left 25, bilateral 1
• Time from admission to study enrolment, days: not reported
• NIHSS: not reported
• Walking speed: not reported
• Berg balance scale: not reported
• Length of hospital stay: not reported
Inclusion criteria: acute ischaemic stroke onMRI or CT imaging, able to walk without
assistance or gait aid within 1 week of admission
Exclusion criteria: aphasia, visual field defect, dementia (Mini-Mental State Examina-
tion score < 23), age > 80 years old, premorbid modified Rankin Scale (mRS) score > 2
due to a history of musculoskeletal disease, severe cardiopulmonary disease or psychiatric
disease, patient refusal to participate in study
Pretreatment: no significant differences between groups at baseline in terms of any of
the collected outcome measures
Setting: inpatient hospital
Methodof recruitment of participants: consecutive patients in acute phase of ischaemic
stroke admitted to Itami Kousei Neurosurgica Hospital within 48 hours from stroke
onset who underwent rehabilitation from April 2016 to March 2017 were enrolled -
specific process of recruitment not described
Informed consent obtained: not specified
Total number randomised: 55 (27 to rehabilitation with accelerometer-based feedback,
28 to usual rehabilitation), 48 completed the study (23 in rehabilitation with accelerom-
eter-based feedback, 25 in usual rehabilitation)
Withdrawals and exclusions: 133 screened for eligibility, 78 excluded (34 older than
80 years old, 19 with premorbid mRS > 2, 11 declined to participate, 8 aphasia or
cognitive impairment, and 6 for other reasons).7 dropped out; 4 from rehabilitation
with accelerometer-based feedback group (1 did not wear accelerometer, 1 declined to
participate, 2 for other reasons) and 3 from usual rehabilitation group (2 withdrew with
less than 3 days of monitoring, 1 declined to participate)
Subgroups measured and/or reported: not specified
Interventions Intervention characteristics
Other intervention alone (inpatient rehabilitation)
• All participants wore accelerometer (Fitbit One) on waist belt 24 hours/day until
discharge, unless bathing
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• All participants underwent 40 to 120 minutes of supervised rehabilitation 5 to 6
times/week. This consisted of physical therapy and occupational therapy: body
stretches, body weight resistance exercise (shoulder flexion and abduction from
anatomic position, squats and calf raises), aerobic exercise (40% to 60% of maximum
predicted heart rate or at intensity of 11 to 13 on Borg scale on cycle ergometer) and a
cool-down period
• Participants who needed to improve balance, walking, or activities of daily living
received specific exercise instruction.
Activity monitor plus other intervention (rehabilitation with accelerometer-based feed-
back)
• Usual inpatient rehabilitation as described above
• After baseline measurement, participants instructed in use of accelerometer-based
feedback to promote hospitalised physical activity: asked by physical therapist to record
measured activity on calendar
• Participant and therapist set activity targets including steps/day (typically 100 to
500 steps more than previous day) or objective activity
• Participant had access to real time feedback on steps, to help achieve daily targets
• Physical therapist and patient reviewed daily activity - participant praised if target
achieved, if target not achieved the physical therapist discussed a modified activity
target with participant by viewing the feedback log
Outcomes Number of steps per day (SPD)
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: number of steps
• Direction: higher is better
• Data value: endpoint
• Notes: data collected via downloading data files to Fitbit online dashboard
software
Exercise energy expenditure
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: kcal
• Direction: higher is better
• Data value: endpoint
• Notes: data collected via downloading data files to Fitbit online dashboard
software
Duration of activity time
• Outcome type: continuous
• Reporting: fully reported
• Unit of measure: minutes/day in light, moderate, and vigorous activity
• Direction: higher is better
• Data value: endpoint
• Notes: data collected via downloading data files to Fitbit online dashboard
software. Duration of activity time calculated for each intensity (light, moderate and
vigorous)
Self-efficacy for physical activity
• Outcome type: 4 subscales with subscale scores ranging from 0 to 100
• Reporting: fully reported
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• Unit of measure: score out of 400
• Direction: higher is better
• Data value: endpoint
• Notes: data collected using Japanese version of self-efficacy for physical activity
score
Identification Sponsorship source: author(s) disclosed receipt of the following financial support for
the research, authorship and/or publication of the article: Sasakawa Scientific Research
Grant (grant no, 28-622) from the Japan Science Society
Country: Japan
Setting: inpatient hospital
Comments: n/a
Authors name: Kazuhiro P Izawa
Institution: Department of International Health Sciences, Graduate School of Health
Sciences, Kobe University, Kobe, Japan
Email: izawapk@harbor.kobe-u.ac.jp
Address: Department of International Health Sciences, Graduate School of Health Sci-
ences, Kobe University, 7-10-2 Tomogaoka, Suma-ku, Kobe 654-0142, Japan
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An independent person who was not in-
volved in enrolment or outcome assess-
ment performed the randomisation using
a computer-generated 1:1 allocation se-
quence and permuted block size of 2. Par-
ticipants were randomly assigned to the
intervention group or control group by
this independent person. The sequence was
concealed until intervention
Allocation concealment (selection bias) Low risk As above
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Unable to blind participants, therapists
were not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk 3 of 4 outcomes collected via objective ac-
celerometer. Physical therapists who were
aware of participants’ group allocations col-
lected outcomes on self-efficacy for physi-
cal activity
Incomplete outcome data (attrition bias)
All outcomes
Low risk Small study, patient withdrawals balanced
between groups
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Selective reporting (reporting bias) Low risk All activity outcomes that would be col-
lected during hospital stay from trial proto-
col reported. Planned outcomes that were
not recorded: stroke recurrence, other car-
diovascular event, post-discharge physical
activity
Other bias Low risk
Mansfield 2015
Methods Study design: randomised controlled trial
Study grouping: parallel group
Aim of study: to determine the benefit of providing feedback regarding characteristics of
patients’ daily walking activity to their physiotherapists as part of a goal-setting process
Unit of allocation: assigned by participants in blocks of 4 to feedback or no feedback
Duration of participation: time of enrolment to inpatient discharge (3 to 26 days of
monitoring; mode = 11 days)
Ethical approval obtained for study: yes
Dates of study: October 2012 to January 2014
Blinding: a blinded research assistant screened and enrolled participants, conducted the
assessments, processed data, and generated reports. Reports for feedback participants
were delivered to the physiotherapist by an investigator who was not involved in data
collection
Physical activity monitor used: lightweight commercially available triaxial accelerom-
eters (Model X6-2mini, Gulf Data Concepts, LLC, Waveland, MS)
Participants Baseline characteristics
Other intervention alone (usual inpatient stroke rehabilitation)min to max
• Age, years, median (interquartile range, IQR; min to max): 61.5 (13; 24 to 81)
• Sex: 12 women, 16 men
• Time since stroke, days, median (IQR; min to max): 23 (20; 12 to 72)
• Stroke type: 22 ischaemic, 6 haemorrhagic
• Side of stroke: 13 left, 13 right, 2 bilateral
• National Institutes of Health Stroke Scale, median (IQR; min to max): 1 (3; 0 to
6)
• Berg Balance Scale, median (IQR; min to max): 39.5 (15; 4-56)
• Chedoke-McMaster Stroke Assessment leg score, median (IQR; min to max): 4
(2; 3 to 7)
• Walking speed, m/s, median (IQR; min to max): 0.52 (0.41; 0.28 to 1.45)
• Usual gait aid: 5 none, 5 cane, 15 wheeled walker-rollator, 3 multiple
• Time from admission to study enrolment, days, median (IQR; min to max): 12
(10; 3 to 42)
• Time from enrolment to discharge, days, median (IQR; min to max): 14 (9; 3 to
36)
• Number days monitored, median (IQR; min to max): 8 (4; 3 to 23)
Activity monitor plus other intervention (usual inpatient rehabilitation + activity mon-
itoring)
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• Age, years, median (IQR; min to max): 64 (19; 22 to 92)
• Sex: 9 women, 20 men
• Time since stroke, days, median (IQR; min to max): 26 (22; 11 to 114)
• Stroke type: 24 ischaemic, 5 haemorrhagic
• Side of stroke: 16 left, 11 right, 2 bilateral
• National Institutes of Health Stroke Scale, median (IQR; min to max): 2 (2; 0 to
7)
• Berg Balance Scale, median (IQR; min to max): 38 (20; 4 to 56)
• Chedoke-McMaster Stroke Assessment leg score, median (IQR; min to max): 4
(2; 2 to 7)
• Walking speed, m/s, median (IQR; min to max): 0.75 (0.42; 0.15 to 1.27)
• Usual gait aid: 8 none, 5 cane, 15 wheeled walker-rollator, 1 multiple
• Time from admission to study enrolment, days, median (IQR; min to max): 10
(15; 3 to 105)
• Time from enrolment to discharge, days, median (IQR; min to max): 14 (13; 4 to
91)
• Number days monitored, median (IQR; min to max): 9 (6; 3 to 26)
Overall
• Age, years, median (IQR; min to max): 63 (17; 22 to 92)
• Sex: 21 women, 36 men
• Time since stroke, days, median (IQR; min to max): 25 (20; 11 to 114)
• Stroke type: 46 ischaemic, 11 haemorrhagic
• Side of stroke: 29 left, 24 right, 4 bilateral
• National Institutes of Health Stroke Scale, median (IQR; min to max): 2 (2; 0 to
7)
• Berg Balance Scale, median (IQR; min to max): 39 (20; 4 to 56)
• Chedoke-McMaster Stroke Assessment leg score, median (IQR; min to max): 4
(2; 2 to 7)
• Walking speed, m/s, median (IQR; min to max): 0.69 (0.46; 0.15 to 1.45)
• Usual gait aid: 13 none, 10 cane, 30 wheeled walker-rollator, 4 multiple
• Time from admission to study enrolment, days, median (IQR; min to max): 11
(13; 3 to 105)
• Time from enrolment to discharge, days, median (IQR; min to max): 14 (11; 3 to
91)
• Number days monitored, median (IQR; min to max): 8 (5; 3 to 26)
Inclusion criteria: individuals with subacute stroke attending inpatient rehabilitation
at Toronto Rehab were recruited if they had a walking-related rehabilitation goal and
were able to walk without supervision at the time of enrolment. People who were not
ambulatory on admission were reassessed for eligibility 2 to 3 times per week until they
either became eligible or were discharged
Exclusion criteria: individuals unable to provide consent were excluded
Pretreatment: at baseline, there were no statistically significant differences in age, sex,
time since stroke or disability between groups
Method of recruitment: individuals with subacute stroke attending inpatient rehabili-
tation at Toronto Rehab were recruited
Total number randomised: 60 (29 to feedback + inpatient rehabilitation, 31 to inpatient
rehabilitation only)
Withdrawals and exclusions: 238 screened for eligibility, 175 excluded after screening
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(138 did not meet inclusion criteria; 37 declined to participate) 3 were eligible but
withdrew prior to randomisation
Inpatient rehabilitation only: 6withdrawals: 2 due to early discharge, 1 due to a change in
medical status, 2 declined further participation, and 1 repeatedly lost the accelerometers
Feedback + inpatient rehabilitation: 3 withdrawals: 2 declined further participation, 1
due to a change in medical status
Number for analysis of gait data at end of activity monitoring: N = 35
Dropouts: n = 3 (withdrew with less than 3 days of monitoring)
Informed consent obtained: provided written informed consent prior to participation
Setting: inpatient rehabilitation
Subgroups measured and/or reported: nil
Interventions Intervention characteristics
Other intervention alone
• Walking rehabilitation: physiotherapist assigned a walking programme of
incrementally increasing difficulty based on rehabilitation goals. Participants received 1
hour of physiotherapy per day
• Goal-setting: physiotherapists had daily opportunities to discuss progress with
physiotherapy-related rehabilitation goals (e.g. walking goals) with participants. In
addition, participants met with their goal co-ordinators (assigned interprofessional
team member) weekly to discuss progress with all rehabilitation goals. Daily
individualised occupational therapy, speech and language pathology, group therapies,
or a combination may have been prescribed to participants on an as-needed basis
• Feedback: physiotherapist relied on participant self-report for the appraisal
portion of the goal-setting process
Activity monitor plus other intervention
• Walking rehabilitation: physiotherapist assigned a walking programme of
incrementally increasing difficulty based on rehabilitation goals. Participants received 1
hour of physiotherapy per day
• Goal-setting: physiotherapists had daily opportunities to discuss progress with
physiotherapy-related rehabilitation goals (e.g. walking goals) with participants.
Additionally, participants met with their goal co-ordinators (assigned interprofessional
team member) weekly to discuss progress with all rehabilitation goals. Daily
individualised occupational therapy, speech and language pathology, and/or group
therapies may have been prescribed to participants on an as-needed basis
• Feedback: a daily report was generated for each participant summarising the
previous days’ walking activity data. Reference values for target steps/day for various
populations, and interpretation of cadence values were also provided. Physiotherapists
of participants assigned to the activity monitor group received the walking activity
report daily as means to appraise achievement of walking goals and subgoals.Walking
reports were provided daily to physiotherapists from the second day of enrolment until
the participant either withdrew or was discharged. Physiotherapists decided how best
to use the information provided given participant-specific goals and language,
communication, cognitive, and mobility impairments
Outcomes Number of steps per day (SPD)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: number of steps
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• Direction: higher is better
• Data value: endpoint
Total daily walking time (minutes)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: minutes
• Direction: higher is better
• Data value: endpoint
Average cadence (steps/min)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: steps/minute
• Direction: higher is better
• Data value: endpoint
Number of bouts > 5 minutes long
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: number
• Direction: higher is better
• Data value: endpoint
Longest bout duration (minutes)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: minutes
• Direction: higher is better
• Data value: endpoint
Self-Selected Walking Speed (SSWS)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: metres/second
• Direction: higher is better
• Data value: endpoint
• Notes: taken on GAITRite over 4 m
Step length symmetry (ratio)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: ratio of left and right
• Direction: lower is better
• Data value: endpoint
• Notes: larger number used as the numerator so all values were > 1
Swing time symmetry (ratio)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: ratio of left and right
• Direction: lower is better
• Data value: endpoint
• Notes: larger number as numerator
Step length variability (cm)
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• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: centimetres
• Direction: lower is better
• Data value: endpoint
• Notes: variability was the average of the standard deviations for the left and right
limbs
Step time variability (ms)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: milliseconds
• Direction: lower is better
• Data value: endpoint
• Notes: variability was the average of the standard deviations for the left and right
limbs
Step width variability (cm)
• Outcome type: continuous outcome
• Reporting: fully reported
• Unit of measure: centimetres
• Direction: lower is better
• Data value: endpoint
• Notes: step width variability was the standard deviation of step width
Stroke self-efficacy (score)
• Outcome type: continuous outcome
• Reporting: fully reported
• Range: 0 to 10
• Unit of measure: score
• Direction: higher is better
• Data value: endpoint
• Notes: this 13-item questionnaire asks participants to rate confidence in
completing various tasks, including walking indoors and outdoors, on a scale from 0 to
10
Identification Sponsorship source: the OntarioMinistry of Health and Long-Term Care, the Ontario
Stroke Network (OSN1101-000149), the Canada Foundation for Innovation, Ontario
Innovation Trust, and the Ministry of Research and Innovation
Country: Canada
Setting: inpatient rehabilitation
Comments: the intervention was provided during inpatient rehabilitation
Authors name: Avril Mansfield
Institution:Toronto Rehabilitation Institute-University HealthNetwork, Toronto, On-
tario, Canada
Email: Avril.Mansfield@uhn.ca
Address: Toronto Rehabilitation Institute, Room 11-117, 550 University Ave, Toronto,
Ontario, Canada M5G 2A2
Notes
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned us-
ing blocked stratified randomisation (block
size = 4) to 1 of 2 groups
Allocation concealment (selection bias) Low risk Concealed group allocation was performed
using a computer-generated random se-
quence by an investigator who was not in-
volved in participant screening
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Reports for activity monitor participants
were delivered to the physiotherapist by an
investigator who was not involved in data
collection. The physiotherapists adminis-
tered goal-setting and planning, including
incorporating the walking activity report
for activity monitor feedback participants.
Participants were not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk A research assistant screened and enrolled
participants, conducted the assessments,
processed the data and generated reports
Incomplete outcome data (attrition bias)
All outcomes
Low risk Number of participants were clearly indi-
cated for all outcomes. Flow of participants
through the study was clearly outlined
Selective reporting (reporting bias) Low risk Tables 2 and 3 presented all outcome data
as indicated.
Other bias Low risk Recruitment methods were sound and
clear.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bird 2016 Wrong intervention
Gandhi 2017 Wrong study design
Koh 2015 Wrong comparator
Martin 2015 Wrong patient population
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Pandey 2013 Wrong study design
Paul 2016 Wrong study design
Sakakibara 2014 Wrong comparator
Seo 2015 Wrong study design
Characteristics of ongoing studies [ordered by study ID]
ACTRN12616001733460p
Trial name or title Feasibility study to evaluate a goal-directed physiotherapy-facilitated walking program for people after stroke
to enhance health and well-being
Methods Study design: randomised controlled trial
Study grouping: parallel
Aim: to investigate the feasibility of using a walking intervention to enhance health and well-being for people
with stroke to inform a future RCT
Unit of allocation: not described
Duration of participation: 12 weeks
Ethical approval obtained for study: yes
Blinding: outcome assessors and data analysis
Physical activity monitor used: Fitbit one™
Participants Inclusion: people with stroke living in the community (including rest homes) who are medically stable to
embark on a walking programme and competent to provide written informed consent, as determined by their
general practitioner (or medical professional). Participants must be independently ambulant (with or without
mobility aids). Individuals under active treatment from a health professional will also be eligible as will those
currently receiving no clinical intervention
Exclusion:peoplewith stroke requiring supervision or assistance to ambulate, thosewith cognitive impairment
and unable to use a Fitbit one™, inability to communicate in English
Method of recruitment process: not described
Number for analysis: 40
Informed consent: written
Setting: community
Subgroups measured: not specified
Interventions Intervention characteristics: physiotherapist-assisted walking goals set weekly in conjunction with step per
day count using the activity monitor
Control: usual care, defined as usual participation in activities of daily living
Outcomes Primary: change in percentage of time spent in sedentary, moderate, and vigorous activity under free-living
conditions as measure by an accelerometer; quality of Life using the Stroke Specific Quality of Life Scale (SS-
QOL); health & wellness using: Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS)
Secondary: resting systolic and diastolic blood pressure measured using a manual blood pressure monitor;
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cardiovascular endurance using the six-minute walk test (6MWT); participant experience of walking interven-
tion using qualitative methods; recruitment - how many people register interest: proportion of respondents
meeting eligibility criteria; number of dropouts at randomisation, during intervention or non-intervention
and at 12-week assessment. Proportion of participants with self-reported or measured cardiovascular risk
factors; walking programme adherence via participant diary; physiotherapy contact time, number of face-to-
face visits, number of video-conferences or phone calls
Starting date 9 December 2016
Contact information Dr Lynne Clay
Address: Centre for Health, Activity and Rehabilitation Research
School of Physiotherapy
University of Otago
PO Box 56
Dunedin 9054
Country: New Zealand
Phone: +64 3 479 5235
Email: lynne.clay@otago.au.nz
Notes -
Kee 2016
Trial name or title SPRITE - a feasibility and pilot study (SPRITE)
Methods Study design: randomised controlled trial
Study grouping: parallel
Aim: to determine if a novel rehabilitation programme, ’The Healthy Brain Rehabilitation Manual’, for
transient ischaemic attack (TIA) or minor stroke patients can be developed, using Medical Research Coun-
cil guidelines for developing complex health service interventions, from an approved home-based cardiac
rehabilitation programme (the ’Heart Manual’), and to undertake feasibility and pilot studies of the novel
programme
Unit of allocation: computer-generated randomisation prior to recruitment, allocations concealed in sealed
opaque envelopes until baseline assessments completed
Duration of participation: 12 weeks
Ethical approval obtained for study: yes
Blinding: baseline assessment blinded, post-intervention assessments not blinded
Physical activity monitor used: pedometer or Fitbit Charge
Participants Inclusion: 18 years and older, men or women, attendee at participating TIA clinical within 4 weeks of a first
suspected TIA, diagnosed with TIA or minor stroke
Exclusion: patients who have experienced more than 1 TIA or stroke, inability to give informed consent,
presenting after 4 weeks of first suspected TIA or minor stroke, contra-indicated for exercise training based
on guidelines of the American College of Sports Medicine
Method of recruitment: consenting attendees at TIA clinic telephoned by researchers to invite participation
Number for analysis: 75
Informed consent: yes
Setting: community
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Subgroups measured: not specified
Interventions No intervention control
Receive usual post-TIA or minor stroke care
Active comparator: manual
Receive usual post-TIA or minor stroke care + ’The Health brain Rehabilitation Manual’ providing informa-
tion regarding secondary prevention, e.g. smoking cessation, physical activity promotion
Active comparator: manual + pedometer 1
Receive usual post-TIA or minor stroke care + ’The Health brain Rehabilitation Manual’ providing infor-
mation regarding secondary prevention, e.g. smoking cessation, physical activity promotion + pedometer to
measure step count, encouraged to keep step-count diary + telephone follow-up by general practitioner or
nurse
Outcomes Primary: rate of recruitment at 12 weeks
Secondary: change in level of physical activity (steps per day and accelerometer data), change in body mass
index, change in quality of life, change in blood pressure, change in physical function (2-minute walk test)
baseline to 12 weeks
Rate of retention at 12 weeks
Starting date March 2016
Contact information Neil Heron nheron02@qub.ac.uk; Frank Kee f.kee@qub.ac.uk
Notes -
Klassen 2015
Trial name or title Determining Optimal poststroke Exercise (DOSE)
Methods Study design: randomised controlled trial
Study grouping: parallel
Aim: to provide preliminary evidence of efficacy of physical exercise dose on ambulatory function in adults
undergoing sub-acute stroke rehabilitation
Unit of allocation: not specified
Duration of participation: 4 weeks intervention, 12 months follow-up
Ethical approval obtained for study: not specified
Blinding: participants will be blinded
Physical activity monitor used: not specified
Participants Inclusion: admitted to hospital for stroke rehabilitation, within 10 weeks of stroke, 19 years or older, expe-
riencing difficulty walking
Exclusion: requires more than 1 person assist for transfer or ambulation, uncontrolled medical condition or
another serious medication condition in addition to stroke, unable to understand or follow directions
Method of recruitment: inpatients invited to participate
Number for analysis: 75
Informed consent: not specified
Setting: inpatient rehabilitation
Subgroups measured: not specified
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Klassen 2015 (Continued)
Interventions Active comparator: stroke management programme
Participants will have usual care, and in addition, be provided with periodic information about their progress
with regard to mobility, using specialised activity monitors
Experimental: stroke monitoring programme
Participants will have usual care, and in addition, be progressed according to customised protocols using
feedback from specialised activity monitors
Experimental: stroke supplementary programme
Participants will have usual care, and in addition, will receive the same as Stroke Monitoring Group and also
receive 1 hour of daily (5 times per week) physical exercise
Outcomes Primary: ambulatory function (6-minute walk test) at 6 and 12 months poststroke
Secondary: ambulatory function (5-Meter Walk Test, Functional Ambulation Classification), balance func-
tion (Berg Balance Scale), quality of life (EuroQol), cognition (Montreal Cognitive Assessment, Digit Sym-
bols Substitution Test, Trail Making Test), depression (Patient Health Questionnaire-9), all at Rehabilitation
discharge (average 4 to 5 weeks post admission), 6, and 12 months poststroke
Heart rate and step count measured during the intervention sessions (from 10 intervention sessions within
the 4 week intervention)
Starting date September 2013
Contact information Chihya Hung, 604-714-4108, chihya.hung@ubc.ca
Notes -
NCT02494245
Trial name or title Increasing physical activity in stroke survivors using STARFISH, an interactive mobile phone app
Methods Study design: randomised controlled trial
Study grouping: parallel
Aim: to compare physical activity in stroke survivors who have undertaken a four-month physical activity
intervention using the STARFISH application with a control group receiving 4 months of usual care
Unit of allocation: not specified
Duration of participation: 4 months
Ethical approval obtained for study: not specified
Blinding: blinded outcome assessors
Physical activity monitor used: STARFISH app
Participants Inclusion: 18 years and older, single unilateral stroke, discharged from active rehabilitation, able to walk
independently with or without orthosis or aid, able to comprehend instruction
Exclusion: history of serious cardiac disease in the previous 6months, uncontrolled blood pressure, significant
neurological or musculoskeletal conditions in addition to stroke, currently participating in another clinical
trial (rehabilitation or pharmacological)
Method of recruitment: community clinics and health services to identify potential participants and provide
them with participant information sheets
Number for analysis: 116
Informed consent: required
Setting: community
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Subgroups measured: not specified
Interventions Intervention:4-month physical activity interventionusing STARFISHappwith the aimof increasingphysical
activity by 3000 steps per day. Participantswill be providedwith a smartphone for the intervention. Participants
will work in groups of 4, but each participant will have their own individualised step count target, based on
their baseline step count. If the participant reaches their step count target on at least 5 days of the week, then
their target will be increased by 5% for the following week, up to a maximum increase of 3000 steps above
baseline. Where a participant fails to reach their step count target, it remains unchanged for the following
week
Control: provided with booklet with general advice on physical activity
Outcomes Primary: change in steps per day (baseline, 4 months, 6 months) measured with ActivPAL
Secondary: change in sedentary time measured with ActivPAL, change in 6-minute walk test, change in 10-
metre walk test, change in Nottingham Extended Actvities of Daily Living Scale, change in Fatigue Severity
Scale, change in Stroke Specific Quality of Life Scale, change in Hospital Anxiety and Depression Scale,
change in blood pressure, change in weight in kg, change in plasma lipid profile, change in heart rate, change
in walking time measured with ActivPAL, liver function, change in C-reactive protein level, change inHbA1C
(all at baseline, 4 months, 6 months)
Starting date July 10 2015
Contact information Aleksandra Dybus, 0141 330 5536, aleksandra.dybus@glasgow.ac.uk
Notes -
NCT02587585
Trial name or title An international randomised clinical trial of activity feedback during inpatient stroke rehabilitation enabled
by smart watches
Methods Study design: randomised controlled trial
Study grouping: parallel
Aim: to determine the effect of augmented-activity feedback by smart watches to support in-patient stroke
rehabilitation
Unit of allocation: not described
Duration of participation: 21 days or point of discharge
Ethical approval obtained for study: yes
Blinding: outcome assessor
Physical activity monitor used: smart watch
Participants Inclusion: admission for acute or subacute inpatient neurorehabilitation of a first stroke at the 2nd Affiliated
Hospital of Anhui University of Traditional Medicine and Acupuncture, Hefei, China; time from onset of
stroke to admission for rehabilitation < 16 weeks; ability to follow a 2-stage command; pick up an object, put
object on table; independent in mobility prior to admission. Participants can use any type of assistive device
and brace needed; able to understand and repeat information related to the informed consent
Exclusion: admission for second stroke; people who are unable to provide consent due to a cognitive impair-
ment
Method of recruitment: via inpatient neurorehabilitation for a first stroke at the 2nd Affiliated Hospital of
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Anhui University of Traditional Medicine and Acupuncture, Hefei, China
Number for analysis: 200
Informed consent: written
Setting: inpatient rehabilitation
Subgroups measured: not specified
Interventions Experimental: feedback against tailored target.
For each 2-hour epoch, the watch calculates the level of activity for the same epoch the day before, and adds
5% as the new target to be achieved
Sham comparator: no feedback
For participants assigned to the control group, the smart watch will not provide any activity feedback against
a target; it simply shows which 2-hour epoch a person is in
Outcomes Primary
Change in activity counts as measured by a triaxial accelerometer from a smart watch from admission to 3
weeks or discharge from rehabilitation
Secondary
Activity goal attainment as measured and provided by the smart watch at 3 weeks, or discharge if sooner
Change in walking speed and spatio temporal characteristics of walking as measured by an inertial sensor on
the lower trunk during a 10-m walk test
Fatigue at baseline, 3 weeks, or discharge from inpatient rehabilitation if sooner, using the Fatigue Severity
Index
Health status on EQ-5D-5L at baseline, 3 weeks, or discharge from inpatient rehabilitation if sooner, and
12 weeks (by telephone). This scale compromises 5 dimensions: mobility, self-care, usual activities, pain or
discomfort, and anxiety or depression
Change in functional mobility as measured by Rivermead Mobility Index (RMI) at baseline, 3 weeks, or
discharge from inpatient rehabilitation if sooner, and 12 weeks (by telephone)
Change in cognitive function as measured by the Montreal Cognitive Assessment (MoCA) at baseline, 3
weeks, or discharge from inpatient rehabilitation if sooner
Change in arm function recovery at baseline, 3 weeks, or discharge from inpatient rehabilitation if sooner,
using a grip dynamometer
Change in performance of activities of daily living as measured by Barthel ADL Index at baseline, 3 weeks,
or discharge from inpatient rehabilitation if sooner
Change in disability as measured byWorldHealth Organisation Disability Assessment Scale (12 item version)
at baseline, 3 weeks, or discharge from inpatient rehabilitation if sooner, and 12 weeks
Adverse events at 3 weeks, or discharge if sooner, and at 12 weeks, self-reported adverse events
Starting date 27 October 2015
Contact information Professor Derick T Wade, MD
Oxford Brooks University
Dr Yun Dong
The 2nd Affiliated Hospital to Anhui University of Tranditional Chinese Medicine
Hefei, Anhui, China
Phone: +86 551 6266 5048
Email: dongyun1003@126.com
Notes
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NCT02835313
Trial name or title Promoting recovery optimisation with WALKing exercise after stroke
Methods Study design: randomised controlled trial
Study grouping: parallel
Aim: to test whether, and for whom, combining fast-walking training with a step-activity monitoring pro-
gramme (FAST+SAM) is superior in improving real-world walking activity compared to fast-walking training
alone (FAST) or a step-activity monitoring and feedback program alone (SAM), in those with chronic stroke
Unit of allocation: not described
Duration of participation: 12 weeks
Ethical approval obtained for study: yes
Blinding: outcome assessor
Physical activity monitor used: step-activity monitor (SAM)
Participants Inclusion: age 21 to 85 years; chronic stroke (> 6 months post stroke); able to walk at self-selected speed
without assistance from another person (assistive devices are allowed); self-selected walking speed > 0.3 m/
s and < 1.0 m/s; average steps/day < 8,000; resting heart rate between 40 and 100 beats per minute; resting
blood pressure between 90/60 and 170/90
Exclusion: evidence of cerebellar stroke; other potentially disabling neurologic conditions in addition to
stroke; lower limb Botulinum toxin injection < 4 months earlier; current participation in physical therapy;
inability to walk outside the home prior to the stroke; coronary artery bypass graft, stent placement or
myocardial infarctionwithin past 3months;musculoskeletal pain that limits activity; inability to communicate
with investigators; score > 1 on question 1b and > 0 on question 1c on the NIH Stroke Scale
Method of recruitment: not specified
Number for analysis: 258
Informed consent: written
Setting: community
Subgroups measured: not specified
Interventions Experimental: FAST+ SAM. Individuals participate in fast-walking training in combination with a step-
activity monitoring programme 3 times/week for 12 weeks
Active Comparator: FAST. Individuals participate in fast-walking training 3 times/week for 12 weeks
Active Comparator: SAM. Individuals participate in a step-activity monitoring programme 3 times/week
for 12 weeks
Outcomes Primary
Steps per day: change in steps per day from pre-intervention to 12 months later
Secondary
Walking speed as measured by the 10-metre walk test: change in walking speed from pre-intervention to 12
months later
Endurance as measured by the 6-minute walk test: change in endurance from pre-intervention to 12 months
later
Oxygen consumption: change in oxygen consumption from pre-intervention to 12 months later
Starting date July 2016
Contact information Darcy Reisman, PT, PhD
University of Delaware
Newark, Delaware, United States, 19712
Phone: 302-764-4701
50Activity monitors for increasing physical activity in adult stroke survivors (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
NCT02835313 (Continued)
Email: dreisman@udel.edu
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Activity monitor + other intervention vs other intervention alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Number of steps per day (x
1000) at end of intervention
3 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Community dwelling (> 6
months post-stroke)
1 27 Mean Difference (IV, Random, 95% CI) -1.93 [-4.41, 0.55]
1.2 Inpatient rehabilitation (<
6 months post-stroke)
2 83 Mean Difference (IV, Random, 95% CI) 1.40 [-0.04, 2.84]
2 Time spent on light, moderate,
vigorous intensity activity
1 Mean Difference (IV, Random, 95% CI) Totals not selected
2.1 Light intensity activity 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Moderate intensity activity 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 Vigorous intensity activity 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
3 Total time walking at end of
intervention
2 Mean Difference (IV, Random, 95% CI) Totals not selected
3.1 Community dwelling (> 6
months post-stroke)
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
3.2 Inpatient rehabilitation (<
6 months post-stroke)
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4 Stroke Impact Scale-16 at end of
intervention
1 Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 Inpatient rehabilitation (<
6 months post-stroke)
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 Activity monitor + other intervention vs other intervention alone, Outcome 1
Number of steps per day (x 1000) at end of intervention.
Review: Activity monitors for increasing physical activity in adult stroke survivors
Comparison: 1 Activity monitor + other intervention vs other intervention alone
Outcome: 1 Number of steps per day (x 1000) at end of intervention
Study or subgroup
activity monitor +
other intervention
other
intervention
alone
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Community dwelling (> 6 months post-stroke)
Danks 2016 13 5.16 (2.5) 14 7.09 (3.96) 100.0 % -1.93 [ -4.41, 0.55 ]
Subtotal (95% CI) 13 14 100.0 % -1.93 [ -4.41, 0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.13)
2 Inpatient rehabilitation (< 6 months post-stroke)
Kanai 2018 23 5.18 (2.31) 25 3.11 (1.15) 54.7 % 2.07 [ 1.02, 3.12 ]
Mansfield 2015 18 6.19 (2.23) 17 5.6 (1.906) 45.3 % 0.59 [ -0.78, 1.96 ]
Subtotal (95% CI) 41 42 100.0 % 1.40 [ -0.04, 2.84 ]
Heterogeneity: Tau2 = 0.71; Chi2 = 2.83, df = 1 (P = 0.09); I2 =65%
Test for overall effect: Z = 1.90 (P = 0.058)
-4 -2 0 2 4
Favours other intervention alone Favours activity monitor + other intervention
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Analysis 1.2. Comparison 1 Activity monitor + other intervention vs other intervention alone, Outcome 2
Time spent on light, moderate, vigorous intensity activity.
Review: Activity monitors for increasing physical activity in adult stroke survivors
Comparison: 1 Activity monitor + other intervention vs other intervention alone
Outcome: 2 Time spent on light, moderate, vigorous intensity activity
Study or subgroup
activity monitor +
other intervention
other
intervention
alone
Mean
Difference
Mean
Difference
N Mean(SD)[min/day] N Mean(SD)[min/day] IV,Random,95% CI IV,Random,95% CI
1 Light intensity activity
Kanai 2018 23 139.5 (52) 25 113.7 (35.1) 25.80 [ 0.48, 51.12 ]
2 Moderate intensity activity
Kanai 2018 23 7.1 (9.4) 25 2.7 (3.8) 4.40 [ 0.28, 8.52 ]
3 Vigorous intensity activity
Kanai 2018 23 3.4 (8.2) 25 0.8 (1.5) 2.60 [ -0.80, 6.00 ]
-50 -25 0 25 50
Favours other intervention alone Favours activity monitor + other intervention
Analysis 1.3. Comparison 1 Activity monitor + other intervention vs other intervention alone, Outcome 3
Total time walking at end of intervention.
Review: Activity monitors for increasing physical activity in adult stroke survivors
Comparison: 1 Activity monitor + other intervention vs other intervention alone
Outcome: 3 Total time walking at end of intervention
Study or subgroup
activity monitor +
other intervention
other
intervention
alone
Mean
Difference
Mean
Difference
N Mean(SD)[minutes] N Mean(SD)[minutes] IV,Random,95% CI IV,Random,95% CI
1 Community dwelling (> 6 months post-stroke)
Danks 2016 13 102 (47.4) 14 141 (70.2) -39.00 [ -83.90, 5.90 ]
2 Inpatient rehabilitation (< 6 months post-stroke)
Mansfield 2015 18 75.9 (25.7) 17 71.5 (22.3) 4.40 [ -11.52, 20.32 ]
-200 -100 0 100 200
Favours other intervention alone Favours activity monitor + other intervention
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Analysis 1.4. Comparison 1 Activity monitor + other intervention vs other intervention alone, Outcome 4
Stroke Impact Scale-16 at end of intervention.
Review: Activity monitors for increasing physical activity in adult stroke survivors
Comparison: 1 Activity monitor + other intervention vs other intervention alone
Outcome: 4 Stroke Impact Scale-16 at end of intervention
Study or subgroup
activity monitor +
other intervention
other
intervention
alone
Mean
Difference
Mean
Difference
N
Mean(SD)[SIS
score] N
Mean(SD)[SIS
score] IV,Random,95% CI IV,Random,95% CI
1 Inpatient rehabilitation (< 6 months post-stroke)
Dorsch 2015 63 72.9 (21.5) 72 71.4 (18.9) 1.50 [ -5.37, 8.37 ]
-20 -10 0 10 20
Favours other intervention alone Favours activity monitor + other intervention
A D D I T I O N A L T A B L E S
Table 1. Outcomes reported in included studies of interest to this review
Pre-specified outcomes Danks 2016 Dorsch 2015 Kanai 2018 Mansfield 2015
Steps per day
√ √ √
Time in moderate-vig-
orous physical activity
Sedentary time
Time in light physical
activity
√
Walking duration
√ √
Fatigue
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Table 1. Outcomes reported in included studies of interest to this review (Continued)
Mood
Quality of life
√
Community participa-
tion
Adverse events: falls,
hospitalisations, death
Pre-specified outcomes as per review protocol (Lynch 2017)
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
1. [mh ˆ“cerebrovascular disorders”] or [mh “basal ganglia cerebrovascular disease”] or [mh “brain ischemia”] or [mh “carotid artery
diseases”] or [mh “intracranial arterial diseases”] or [mh “intracranial arteriovenous malformations”] or [mh “intracranial embolism
and thrombosis”] or [mh “intracranial hemorrhages”] or [mh ˆstroke] or [mh “brain infarction”] or [mh ˆ“stroke, lacunar”] or [mh
ˆ“vasospasm, intracranial”] or [mh ˆ“vertebral artery dissection”]
2. (stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH):ti,ab,kw (Word variations have
been searched)
3. ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying)
near/5 (isch?emi* or infarct* or thrombo* or emboli* or occlus* or hypoxi*)):ti,ab,kw (Word variations have been searched)
4. ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid) near/5 (h?
emorrhag* or h?ematoma* or bleed*)):ti,ab,kw (Word variations have been searched)
5. [mh hemiplegia] or [mh paresis] or [mh “Gait Disorders, Neurologic”]
6. (hemipleg* or hemipar* or paresis or paraparesis or paretic):ti,ab,kw (Word variations have been searched)
7. {or #1-#6}
8. [mh ˆfeedback] or [mh “feedback, physiological”] or [mh ˆ“feedback, sensory”]
9. [mh ˆ“monitoring, physiologic”] or [mh “monitoring, ambulatory”]
10. [mh ˆ“activity tracker”] or [mh accelerometry]
11. ((physical or physiolog* or perform* or fit* or train* or activ* or endur* or exercise) near/3 (track* or monitor* or measur* or
device* or app*)):ti,ab,kw (Word variations have been searched)
12. ((step* or walk*) near/3 (count* or meter* or daily)):ti,ab,kw (Word variations have been searched)
13. (pedometer* or actigraph* or acceleromet*):ti,ab,kw (Word variations have been searched)
14. [mh ˆtelemedicine]
15. [mh ˆ“mobile applications”] or [mh ˆ“cell phones”] or [mh ˆsmartphone] or [mh ˆmicrocomputers] or [mh ˆ“computers,
handheld”]
16. ((cell* or smart* or mobile or android or internet or web) near/3 (comput* or device or app* or phone)):ti,ab,kw (Word
variations have been searched)
17. {or #8-#16}
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18. #7 and #17
Appendix 2. MEDLINE Ovid search strategy
1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
cerebral small vessel diseases/ or exp intracranial arterial diseases/ or exp “intracranial embolism and thrombosis”/ or exp intracranial
hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying)
adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. hemiplegia/ or exp paresis/ or exp Gait Disorders, Neurologic/
6. (hemipleg$ or hemipar$ or paresis or paraparesis or paretic).tw.
7. or/1-6
8. feedback/ or exp feedback, physiological/ or feedback, sensory/
9. monitoring, physiologic/ or exp monitoring, ambulatory/
10. activity tracker/ or exp accelerometry/
11. ((physical or physiolog$ or perform$ or fit$ or train$ or activ$ or endur$ or exercise) adj3 (track$ or monitor$ or measur$ or
device$ or app$)).tw.
12. ((step$ or walk$) adj3 (count$ or meter$ or daily)).tw.
13. (pedometer$ or actigraph$ or acceleromet$).tw.
14. telemedicine/
15. Mobile Applications/ or cell phones/ or smartphone/ or microcomputers/ or computers, handheld/
16. ((cell$ or smart$ or mobile or android or internet or web) adj3 (comput$ or device or app$ or phone)).tw.
17. or/8-16
18. Randomized Controlled Trials as Topic/
19. Random Allocation/
20. Controlled Clinical Trials as Topic/
21. control groups/
22. clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or
clinical trials, phase iv as topic/
23. double-blind method/
24. single-blind method/
25. Placebos/
26. placebo effect/
27. cross-over studies/
28. randomized controlled trial.pt.
29. controlled clinical trial.pt.
30. (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.
31. (random$ or RCT or RCTs).tw.
32. (controlled adj5 (trial$ or stud$)).tw.
33. (clinical$ adj5 trial$).tw.
34. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
35. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
36. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
37. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
38. (cross-over or cross over or crossover).tw.
39. (placebo$ or sham).tw.
40. trial.ti.
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41. (assign$ or allocat$).tw.
42. controls.tw.
43. or/18-42
44. 7 and 17 and 43
Appendix 3. Embase search strategy
1. cerebrovascular disease/ or brain disease/ or exp basal ganglion hemorrhage/ or exp brain hemangioma/ or exp brain hematoma/
or exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid artery disease/ or exp cerebral artery disease/
or exp cerebrovascular accident/ or exp cerebrovascular malformation/ or exp intracranial aneurysm/ or exp occlusive cerebrovascular
disease/ or exp vertebrobasilar insufficiency/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying)
adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. exp hemiplegia/ or exp paresis/ or neurologic gait disorder/
6. (hemipleg$ or hemipar$ or paresis or paraparesis or paretic).tw.
7. or/1-6
8. feedback system/ or monitor/ or ambulatory monitoring/ or self monitoring/ or personal monitor/ or personal monitoring/ or
physiologic monitoring/ or exp sensory feedback/
9. exp mobile phone/ or smartphone/ or mobile application/
10. computer/ or microcomputer/ or minicomputer/ or personal digital assistant/
11. telemedicine/ or telehealth/ or medical device/ or devices/
12. ((cell$ or smart$ or mobile or android or internet or web) adj3 (comput$ or device or app$ or phone)).tw.
13. accelerometer/ or accelerometry/ or actimetry/ or pedometer/
14. ((physical or physiolog$ or perform$ or fit$ or train$ or activ$ or endur$ or exercise) adj3 (track$ or monitor$ or measur$ or
device$ or app$)).tw.
15. ((step$ or walk$) adj3 (count$ or meter$ or daily)).tw.
16. (pedometer$ or actigraph$ or acceleromet$).tw.
17. or/8-16
18. Randomized Controlled Trial/ or “randomized controlled trial (topic)”/
19. Randomization/
20. Controlled clinical trial/ or “controlled clinical trial (topic)”/
21. control group/ or controlled study/
22. clinical trial/ or “clinical trial (topic)”/ or phase 1 clinical trial/ or phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4 clinical
trial/
23. Crossover Procedure/
24. Double Blind Procedure/
25. Single Blind Procedure/ or triple blind procedure/
26. placebo/ or placebo effect/
27. (random$ or RCT or RCTs).tw.
28. (controlled adj5 (trial$ or stud$)).tw.
29. (clinical$ adj5 trial$).tw.
30. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.
31. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.
32. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.
33. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.
34. (cross-over or cross over or crossover).tw.
35. (placebo$ or sham).tw.
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36. trial.ti.
37. (assign$ or allocat$).tw.
38. controls.tw.
39. or/18-38
40. 7 and 17 and 39
Appendix 4. CINAHL search strategy
1. (MH “Cerebrovascular Disorders”) OR (MH “Basal Ganglia Cerebrovascular Disease+”) OR (MH “Carotid Artery Diseases+”)
OR (MH “Cerebral Ischemia+”) OR (MH “Cerebral Vasospasm”) OR (MH “Intracranial Arterial Diseases+”) OR (MH “Intracranial
Embolism and Thrombosis”) OR (MH “Intracranial Hemorrhage+”) OR (MH “Stroke”) OR (MH “Vertebral Artery Dissections”)
2. TI ( stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH ) or AB ( stroke* or
poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH )
3. TI ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial
or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-
occupying ) or AB ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or
supratentorial or middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or
space-occupying )
4. TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypoxi* ) or AB ( ischemi* or ischaemi* or infarct*
or thrombo* or emboli* or occlus* or hypox* )
5. S3 and S4
6. TI ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or
infratentorial or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) or AB (
brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or
supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid )
7. TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or
haematoma* or hematoma* or bleed* )
8. S6 and S7
9. (MH “Hemiplegia”)
10. TI ( hemipleg* or hemipar* or paresis or paretic ) or AB ( hemipleg* or hemipar* or paresis or paretic )
11. S1 OR S2 OR S5 OR S8 OR S9 OR S10
12. (MH “Wearable Sensors”) OR (MH “Accelerometers”) OR (MH “Pedometers”) OR (MH “Monitoring, Physiologic”) OR
(MH “Actigraphy”)
13. (MH “Computers, Portable+”) OR (MH “Minicomputers”) OR (MH “Microcomputers”) OR (MH “Telehealth”) OR (MH
“Cellular Phone+”)
14. (MH “Feedback”) OR (MH “Biofeedback”)
15. TI ( ((physical or physiolog* or perform* or fit* or train* or activ* or endur* or exercise) N3 (track* or monitor* or measur* or
device* or app*)) ) OR AB ( ((physical or physiolog* or perform* or fit* or train* or activ* or endur* or exercise) N3 (track* or
monitor* or measur* or device* or app*)) )
16. TI ( ((step* or walk*) N3 (count* or meter* or daily)) ) OR AB ( ((step* or walk*) N3 (count* or meter* or daily)) )
17. TI ( (pedometer* or actigraph* or acceleromet*) ) OR AB ( (pedometer* or actigraph* or acceleromet*) )
18. TI ( ((cell* or smart* or mobile or android or internet or web) N3 (comput* or device or app* or phone)) ) OR AB ( ((cell* or
smart* or mobile or android or internet or web) N3 (comput* or device or app* or phone)) )
19. S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18
20. (MH “Randomized Controlled Trials”) or (MH “Random Assignment”) or (MH “Random Sample+”)
21. (MH “Clinical Trials”) or (MH “Intervention Trials”) or (MH “Therapeutic Trials”)
22. (MH “Double-Blind Studies”) or (MH “Single-Blind Studies”) or (MH “Triple-Blind Studies”)
23. (MH “Control (Research)”) or (MH “Control Group”) or (MH “Placebos”) or (MH “Placebo Effect”)
24. (MH “Crossover Design”) OR (MH “Quasi-Experimental Studies”)
25. PT (clinical trial or randomized controlled trial)
26. TI (random* or RCT or RCTs) or AB (random* or RCT or RCTs)
27. TI (controlled N5 (trial* or stud*)) or AB (controlled N5 (trial* or stud*))
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28. TI (clinical* N5 trial*) or AB (clinical* N5 trial*)
29. TI ((control or treatment or experiment* or intervention) N5 (group* or subject* or patient*)) or AB ((control or treatment or
experiment* or intervention) N5 (group* or subject* or patient*))
30. ((control or experiment* or conservative) N5 (treatment or therapy or procedure or manage*)) or AB ((control or experiment*
or conservative) N5 (treatment or therapy or procedure or manage*))
31. TI ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*)) or AB ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*))
32. TI (cross-over or cross over or crossover) or AB (cross-over or cross over or crossover)
33. TI (placebo* or sham) or AB (placebo* or sham)
34. TI trial
35. TI (assign* or allocat*) or AB (assign* or allocat*)
36. TI controls or AB controls
37. TI (quasi-random* or quasi random* or pseudo-random* or pseudo random*) or AB (quasi-random* or quasi random* or
pseudo-random* or pseudo random*)
38. S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34
OR S35 OR S36 OR S37
39. S11 AND S19 AND S38
Appendix 5. SPORTDiscus search strategy
1. DE “CEREBROVASCULAR disease” OR DE “BRAIN -- Hemorrhage” OR DE “CEREBRAL embolism & thrombosis” OR
DE “STROKE” OR DE “BRAIN -- Wounds & injuries” OR DE “BRAIN damage” OR DE “CEREBROVASCULAR disease --
Patients”
2. TI ( stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH ) or AB ( stroke
or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH )
3. ( TI ( brain* or cerebr* or cerebell* or intracran* or intracerebral ) or AB ( brain* or cerebr* or cerebell* or intracran* or
intracerebral ) ) and ( TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* ) or AB ( ischemi* or ischaemi* or
infarct* or thrombo* or emboli* or occlus* ) )
4. ( TI ( brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid ) or AB ( brain* or cerebr* or cerebell* or
intracerebral or intracranial or subarachnoid ) ) and ( TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or
AB ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) )
5. DE “HEMIPLEGIA” OR DE “HEMIPLEGICS” OR DE “GAIT disorders”
6. TI ( hemipleg* or hemipar* or paresis or paretic ) or AB ( hemipleg* or hemipar* or paresis or paretic )
7. S1 OR S2 OR S3 OR S4 OR S5 OR S6
8. DE “PATIENT monitoring” OR DE “PATIENT self-monitoring”
9. DE “SMARTPHONES” OR DE “MOBILE apps”
10. DE “PHYSICAL activity -- Measurement” OR DE “EQUIPMENT & supplies” OR DE “AUTOMATIC tracking” OR DE
“WEARABLE technology” OR DE “ACCELEROMETERS” OR DE “PEDOMETERS” OR DE “MOTION detectors” OR DE
“MEDICAL technology”
11. TI ( ((physical or physiolog* or perform* or fit* or train* or activ* or endur* or exercise) N3 (track* or monitor* or measur* or
device* or app*)) ) OR AB ( ((physical or physiolog* or perform* or fit* or train* or activ* or endur* or exercise) N3 (track* or
monitor* or measur* or device* or app*)) )
12. TI ( ((step* or walk*) N3 (count* or meter* or daily)) ) OR AB ( ((step* or walk*) N3 (count* or meter* or daily)) )
13. TI ( (pedometer* or actigraph* or acceleromet*) ) OR AB ( (pedometer* or actigraph* or acceleromet*) )
14. TI ( ((cell* or smart* or mobile or android or internet or web) N3 (comput* or device or app* or phone)) ) OR AB ( ((cell* or
smart* or mobile or android or internet or web) N3 (comput* or device or app* or phone)) )
15. S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14
16. S7 AND S15
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Appendix 6. Trial register search strategy
1. Stroke AND “activity monitor”
2. Stroke AND “mobile phone”
3. Stroke AND “app”
C O N T R I B U T I O N S O F A U T H O R S
DS, EL, TJ, LJ, NF, SKu, SKr, CE, MC, KB, HJ, NM reviewed titles and abstracts
LJ, NF, DS, MC, HJ, EL, TJ reviewed full text articles
TJ created data extraction template in Covidence
TJ, KB, SKr, EL extracted data from included studies
TJ, SKr, LJ, EL assessed risk of bias of included studies
SKr, CE, SKu, EL analysed the data
SKr, KB performed GRADE assessment
EL, NF drafted Results
EL, KB, NM, TMJ, LJ drafted Discussion
EL, NF drafted Conclusions and Implications for Practice
SKu drafted Plain Language Summary
MC drafted abstract
CE proof-read and edited final draft
DS collected and recorded data regarding ongoing studies
All authors read and reviewed the completed draft.
D E C L A R A T I O N S O F I N T E R E S T
EAL: none known.
KB: none known.
MC: none known.
NF: none known.
HJ: none known.
LJ: none known.
TMJ: none known.
SKr: none known.
SKu: none known.
NM: none known.
DS: none known.
CE: none known.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Due to the small number of included studies, we were not able to perform the planned subgroup or sensitivity analyses.
We only identified individually randomised trials for this review, so we did not need to analyse for unit-of-analysis issues as planned in
our review protocol (Lynch 2017).
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise; ∗Fitness Trackers; ∗Survivors; Randomized Controlled Trials as Topic; Stroke Rehabilitation [∗instrumentation; methods];
Time Factors
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MeSH check words
Adult; Aged; Aged, 80 and over; Humans; Middle Aged; Young Adult
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